What is the current status of quantification and nuclear medicine in cardiology?

European Journal of Nuclear Medicine

Volumn 23, Issue 7, 1996, Pages 815-851

  Hör, Gustav ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; CARDIOMYOPATHY; CORONARY ARTERY DISEASE; HEART SCINTISCANNING; NUCLEAR MEDICINE; REVIEW;

ADULT; CARDIOLOGY; CHILD; CORONARY DISEASE; ECHOCARDIOGRAPHY; FEMALE; HEART; HEART DISEASES; HEART TRANSPLANTATION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NUCLEAR MEDICINE;

EID: 0029933754     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00843713     Document Type: Review

References (483)

1. Marcus ML, Schelbert HR, Skorton DJ, Wolf GL. Cardiac imaging - a comparison to Braunwald's heart disease. Philadelphia: Saunders, 1991.
2. Adam WE, Tarkowska A. Evaluation of myocardial function using gated blood pool procedures. In: Pabst HW, Adam WE, Ell P, Hör G, Kriegel H, eds. Handbook of nuclear medicine. Stuttgart: Gustav Fischer; 1992; 2: 73-123.
3. Hör G. Heart and nuclear medicine (1924-1994). In: Limouris G, ed. Nuclear cardiology, Athens: Mediterra; 1994: 29-39.
4. Brucer M. A chronology of nuclear medicine 1600-1989. In: St. Louis: Heritage, 1990.
5. Büll U. Kleinhaus E, Reske SN. Herz-Kreislauf-System. In: Büll U, ed. Nuklearmedizin. Stuttgart: Thieme; 1994: 203-246.
6. Hoffmann G, Kleine N. Eine neue Methode zur unblutigen Messung des Schlagvolumens am Menschen über viele Tage mit Hilfe von radioaktiven Isotopen. Verhandl Dtsch Ges Kreislaufforsch; 1965; 31:1-4.
7. 201Tl-redistribution analysis in early and delayed myocardial scintigrams of patients with coronary heart disease. Eur J Nucl Med 1979; 4: 343-350.
8. Standke R, Hör G, Klepzig H Jr, Maul FD, Bussmann WD, Kaltenbach M. Sectoranalysis of left ventricular function by fully automated equilibrium radionuclide ventriculography. Int J Cardiac Imag 1985; 1: 87-97.
9. 201Thallium - Szintimetrie des Herzens als neues Verfahren zur funktionellen Differenzierung der koronaren Herzkrankheit. Fortschr Röntgenstr 1976; 124: 434-443.
10. Stirner H, Buell U, Kleinhans E, Bares R, Grosse W. Myocardial kinetics of Tc-99m-hexakis (2-methoxy-isobutyl-isonitrile) (HMIBI) in patients with coronary heart disease: a comparative study versus 201 Tl with SPECT. Nucl Med Commun 1988; 9: 15-23.
11. Verani MS, Jeroudi MO, Mahmarian JJ, Boyce TM. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2 methoxyisobutyl isonitrile. J Am Coll Cardiol 1988; 12: 1573-1581.
12. Klepzig H, Hör G, Teupe C. Bildgebende Verfahren in der Kardiologie - Koronare Herzkrankheit. Internist 1994; 35: 1056-1065.
13. Maddahi J, Garcia EV, Berman DS, Waxman A, Swan HJC, Forrester J. Improved noninvasive assessment of coronary artery disease by quantitative analysis of regional stress myocardial distribution and wash-out of thallium-201. Circulation 1981; 64: 924-935.
14. 201Tl myocardial scintigram prior to and after TAP. Resp Circ (Tokyo) 1980; 28: 777-778.
15. Wackers FJT, Fetterman RC, Mattera JA, Clements JP. Quantitative planar thallium-201 stress scintigraphy: a critical evaluation of the method. Semin Nucl Med 1985; 15: 46-66.
16. 201Tl-SPECT: results of a ROI-based method in 108 patients with CHD. Nucl Med 1987; 26: 234-240.
17. Schicha H, Rentrop P, Facorro L, Karsch R, Blanke H. Ergebnisse der quantitativen Myokardszintigraphie mit Thallium-201 in Ruhe und unter maximaler Belastung - Kritische Analyse des prädiktiven Wertes und der klinischen Anwendung. Z Kardiol 1980; 69: 31-42.
18. 201TI myocardial scintigrams: a multicenter trial. J Nucl Med 1986; 27: 17-25.
19. Sigal SL, Soufer R, Fetterman RC,et al. Reproducibility of quantitative planar thallium-201 scintigraphy: quantitative criteria for reversibility of myocardial perfusion defects. J Nucl Med 1991; 32: 759-765.
20. Kiat H, van Train KF, Friedman JD, Germano G, Silagan G, Wang FP, Maddahi J, Prigent F, Berman DS. Quantitative stress-redistribution thallium-201 SPECT using prone imaging: methodologic development and validation. J Nucl Med 1992; 33: 1509-1515.
21. Palmer J, Pahlm O, White T, Lyttkens K. Quantitative evaluation of tomographic 201-thallium myocardial scintigraphy. Eur J Nucl Med 1988; 14: 17-20.
22. Zaret BL, Wackers FJ. Nuclear cardiology II (second of two parts). N Engl J Med 1993; 329: 855-863.
23. Ell PJ, Bourguignon MH, Pauwels EKJ, Martin-Comin J, de Roo M, Dige-Pertersen H. Nuclear medicine in cardiology: a position paper for an open debate. Eur J Nucl Med 1995; 22: 189-192.
24. Pennell DJ, Underwood RU, Costa DC, Ell PJ. thallium myocardial perfusion tomography in clinical cardiology. In: London: Springer, 1994.
25. von Schultheß KG. Editorial. Schweiz Rundsch Med Prax 1993; 82: 899-900.
26. Early PJ. Licensing issues for the nuclear cardiologist. J Nucl Cardiol 1994; 1: 171-176.
27. Kloner RA, Tubau JF. Application of nuclear cardiology to the diagnosis of stunned and hibernating myocardium. J Nucl Cardiol 1994; 1: 490-491.
28. Ritchie JL, Gibbons RJ, Johnson LL, Maddahi J, Schelbert HR, Wackers FJT, Zaret BL. Task force 5: training in nuclear cardiology. J Am Coll Cardiol 1995; 25: 1-34.
29. Bonow RO, Berman DS, Gibbons RJ, Johnson LL, Rumberger JA, Schwaiger M, Wackers FJT. Cardiac positron emission tomography (a report for health professionals from the Committee on Advanced Cardiac Imaging and Technology of the Council on Clinical Cardiology, American Heart Association. Circulation 1991; 84: 447-454.
30. Schelbert HR, Maddahi J. Clinical PET: quo vadis? J Nucl Cardiol 1994; 1:576-579.
31. Hundeshagen H, Biersack HJ, Bull U, Felix R, Günnewig BJ, Heiß WD, Hör G, Jordan K, Knapp WH. Müller-Gärtner HW, Reiners C, Reske S, Schicha H, Schober O, Schwaiger M. Stöcklin G, Strauss LG. Positronen-Emissions-Tomographie (klinische Forschung, diagnostische Wertigkeit, zukünftige Entwicklung)-Standortbestimmung 1994 [Arbeitsgemeinschaft PET der Deutschen Gesellschaft für Nuklearmedizin (DGN)]. Nucl Med 1994; 33: 145-153.
32. Schelbert H, Bonow O, Geltman E, Maddahi J, Schwaiger M. Position statement: clinical use of cardiac positron emission tomography (position paper of the Cardiovascular Council of the Society of Nuclear Medicine). J Nucl Med 1993; 34: 1385-1388.
33. Schelbert HR. Metabolic imaging to assess myocardial viability. J Nucl Med 1994; 35: 8S-14S.
34. DePuey EG. Borer JS, Brown KA, Cerqueira MD, LaManna M, Moore WH, Wackers FJT. Cardiovascular nuclear medicine training guidelines. J Nucl Med 1994; 35: 169-178.
35. Gibbons RJ. The impact of emerging guidelines on nuclear cardiology. J Nucl Cardiol 1994; 1: 580-583.
36. Fritzsche H, Bergmann H, Fridrich L, Köhn H, Lind P, Mlczoch J, Mostbeck A, Porenta G. Die Thalliumszintigraphie des Myokards. Nucl Med 1995; 34: 61-67.
37. Zaret BL, Beller GA. Nuclear cardiology-state of the art and future directions. Year Book: Mosby, 1993.
38. Pohost GM, Zir LM, Moore RH, McKusick KA. Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201. Circulation 1977; 55: 294-302.
39. Standke R, Hör G, Maul FD. Fully automated sectorial equilibrium radionuclide ventriculography. Eur J Nucl Med 1983; 8: 77-83.
40. Hör G, Standke R, Klepzig H Jr. Maul FD, Tüngerthal S, Tezak S, Reifart N, Kanemoto N, Happ J, Baum RP. Äquilibrium - Radionuklid-Ventrikulographie: Vergleich mit Echokardiographie und digitaler Subtraktionsangiokardiographie; Multiparameterbewertung. Der Nuklearmediziner 1986; 9: 211-234.
41. Hör G, Zöller A, Klepzig H Jr, Hartmann A, Maul FD, Hertel A, Gürtner C, Kranert T, Baum RP. Klinische Relevanz der Äquilibrium-Radionuklidventrikulographie. Med Klinik 1994; 89: 442-445.
42. Iskandrian AS, Verani MS, Heo J. Pharmacological stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease. J Nucl Cardiol 1994; 1: 94-111.
43. Bisi G, Scigara R, Bull U, Britton KE, Eilles C, Eißner D, Hahn K, Höffken H, Joseph K, McKillop JH, Larock MP, Müller SP, Reiners C, Rigo P. Assessment of ventricular function with first-pass radionuclide angiography using technetium 99m hexakis-2-methoxyisobutylisonitrile: a European multi-centre study. Eur J Nucl Med 1991; 18: 178-183.
44. Borges-Neto S, Coleman RE, Jones RH. Perfusion and function at rest and treadmill exercise using technetium-99m-sestamibi: comparison of one- and two-day protocols in normal volunteers. J Nucl Med 1990; 31: 1128-1132.
45. Giering LP, Smith JE. Industrial perspective: from IND to NDA. J Nucl Cardiol 1995; 2: 66-70.
46. Maisey MN. Controversies in nuclear medicine-analysis of 201 Tl myocardial images. Nucl Med Commun 1991; 12: 323-332.
47. Patterson RE, Horowitz SF, Eisner RL. Comparison of modalities to diagnose coronary artery disease. Semin Nucl Med 1994; 24: 286-310.
48. Pozzoli MMA, Fioretti PM, Salustri A, Reijs AEM, Roelandt JRTC. Exercise echocardiography and technetium-99m MIBI single-photon emission computed tomography in the detection of coronary artery disease. Am J Cardiol 1991; 67: 350-355.
49. Mertes H, Sawada SG, Ryan T, Segar DS, Kovacs R, Foltz J, Feigenbaum H. Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Circulation 1993; 88: 15-19.
50. Salustri A, Pozzoli MMA, Reijs AEM, Fioretti PM. Roelandt JRTC. Comparison of exercise echocardiography with myocardial perfusion scintigraphy for the diagnosis of coronary artery disease. Herz 1991; 16: 388-394.
51. Sobel BE, Willerson JT. Current opinion in cardiology. Philadelphia: Current Science, 1993; 8: 889-1026.
52. Bach DS, Hepner A, Marcovitz PA, Armstrong WF. Dobutamine stress echocardiography: prevalence of a non ischemic response in a low-risk population. Am Heart J 1993; 125: 1257-1261.
53. Pirelli S, Danzi G, Massa D, Piccalo G, Faletra F, Cannizzaro G, Sarullo F, Picano E, De Vita C, Campolo L, Exercise thallium scintigraphy versus high-dose dipyridamole echocardiography testing for detection of asymptomatic restenosis in patients with positive exercise tests after coronary angioplasty. Am J Cardiol 1993; 71: 1052-1056.
54. Poldermans D, Fioretti PM, Forster T, Thomson IR, Börsma E, Elsaid EM, Dubois NA, Rölandt JR, Vanurk H. Dobutamine stress echocardiography for assessment for perioperative cardiac risk in patients undergoing major vascular surgery. Circulation 1993; 87: 1506-1512.
55. Cigarroa CG, deFilippi CR, Brickner ME, Alvarez LG, Wait MA, Grayburn PA. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993; 88: 430-436.
56. Marcassa C, Marzullo P, Parodi O, Sambucetti G, L'Abbate A. A new method for noninvasive quantitation of segmental myocardial wall thickening using technetium-99m 2-methoxy-isobutyl-isonitrile scintigraphy-results in normal subjects. J Nucl Med 1990; 31: 173-177.
57. Prezio JA, Ackerhalt RE. Positron emission tomography as a multi-institutional effort. Semin Nucl Med 1992; 22: 189-192.
58. Rozanski A, Diamond GA, Forrester JS, Berman DS, Morris D, Swan HJC. Alternative referent standards for cardiac normality (implications for diagnostic testing). Ann Intern Med 1984; 101: 164-171.
59. Eisner RL, Tamas MJ, Cloninger K, Shonkoff D, Dates JA, Gober AM, Dunn DW, Malko JA. Normal SPECT thallium201 bull's eye display: gender differences. J Nucl Med 1988; 29: 1901-1909.
60. Estorch M, Carrio I, Lopez-Pousa J, Berna L, Torres G, Intensity of myocardial 123-I-M1BG uptake relates to age [abstract]. Eur J Nucl Med 1994; 8: 787.
61. Esquerre JP, Gantet P, Ouhayoun E, Granier P. Normalisation of stress and delayed thallium-201 myocardial SPECT: where is the normal reference area? J Nucl Med 1991; 32: 1901-1903.
62. Ceriani L, Giovanella L, Verna E, Bianchi L, Roncari G, Tarolo GL. Assessment of myocardium at risk during coronary occlusion by 99m-Tc-sestamibi: comparison between three tomographic methods of quantification [abstract]. J Nucl Cardiol 1995; 2: S3.
63. Freeman LM, Blaufox MD, eds. Quantitative SPECT imaging. Semin Nucl Med 1989; 19: 1-61.
64. Nuyts J, Mortelsmans L, Suetens P, Oosterlinck A, de Rou M. Model-based quantification of myocardial perfusion images from SPECT. J Nucl Med 1989; 30: 1992-2001.
65. Fleming JS, Alaamer AA, Perring S. A technique for the absolute quantification of I-131 radiopharmaceuticals using SPECT. Nucl Med Commun 1993; 14: 498-505.
66. 201Tl myocardial scintigraphy: current status in coronary artery disease. Results of sensitivity/specificity in 3092 patients and clinical recommendations. Nucl Med 1981; 3: 136-147.
67. Detrano R, Janosi A, Lyons P, Marcondes G, Abbassi N, Froelicher VF. Factors affecting sensitivity and specificity of a diagnostic test: the exercise thallium scintigram. Am J Med 1988; 84: 699-708.
68. Loutfi I, Singh A. Myocardial perfusion defects resulting from conditions other than atherosclerosis. Semin Nucl Med 1994; 24: 354-356.
69. Alazraki NP, Krawczynska EG, DePuey EG, Ziffer JA, Vansant JP, Pettigrew RI, Taylor A, King SB, Garcia EV. Reproducibility of thallium-201-exercise SPECT studies. J Nucl Med 1994; 35: 1237-1244.
70. Simons M, Parker JA, Udelson JE, Gervino EV. The role of clinical data in interpretation of perfusion images. J Nucl Med 1994; 35: 740-741.
71. Chouraqui P, Maddahi J, Ostrzega E, van Train K. Quantitative exercise thallium-201 rotational tomography for evaluation of patients with prior myocardial infarction. Am J Cardiol 1990; 66: 151-157.
72. Stöcklin G. Tracers for metabolic imaging of brain and heart. Eur J Nucl Med 1992; 19: 527-551.
73. Simons M, Parker JA, Donohoe KJ, Udelson JE, Gervino EV. The impact of clinical data on interpretation of thallium scintigrams. J Nucl Cardiol 1994; 1: 365-371.
74. Hör G. Myocardial scintigraphy - 25 years after start. Eur J Nucl Med 1988; 13: 619-636.
75. Picano E, Marzullo P, Gigli G, Reisenhofer B, Parodi O, Distante A, L'Abbate A. Identification of viable myocardium by dipyridamole-induced improvement in regional left ventricular function assessed by echocardiography in myocardial infarction and comparison with thallium scintigraphy at rest. Am J Cardiol 1992; 70: 703-710.
76. Galanti G, Sciagra R, Comeglio M, Taddei T, Bonechi F, Giusti F, Malfanti P, Bisi G. Diagnostic accuracy of peak exercise echocardiography in coronary artery disease: comparison with thallium-201 myocardial scintigraphy. Am Heart J 1991; 122: 1609-1616.
77. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994; 23: 617-626.
78. Aldrich HR, Reichek N. Stress echocardiography. Curr Opin Cardiol 1993; 8: 978-987.
79. Young M, Pan W, Wiesner J, Bullough D, Browne G, Balow G, Potter S, Metzner K, Mullane K. Characterization of arbutamine: a novel catecholamine stress agent for diagnosis of coronary artery disease. Drug Develop Res 1994; 32: 19-28.
80. Mertes H, Erbel R, Nixdorff U, Mohr-Kahaly S, Krüger S, Meyer J. Exercise echocardiography for the evaluation of patients after nonsurgical coronary artery revascularization. J Am Coll Cardiol 1993; 21: 1087-1093.
81. 99mTc-MIBI single-photon emission tomograpy: non-exercise-dependent detection of haemodynamically significant coronary artery stenoses. Eur J Nucl Med 1994; 21: 537-544.
82. Oosterhuis WP, Niemeyer MG, Kuijper AFM, Zwindermann AH, Breeman A, Ascoop CAPL, Verzijlbergen FJ, van der Wall EE, Pauwels EKJ. Evaluation of the incremental diagnostic value and impact on patient treatment of thallium scintigraphy. J Nucl Med 1992; 33: 1727-1734.
83. Schober O, Moser E. Transfer from PET to SPET in cardiology, but the unit of reference is still the patient. Eur J Nucl Med 1994; 21: 477-480.
84. Ratib OM, Mankovich NJ. Quantitative coronary arteriography: design and validation. Radiology 1988; 167: 743-747.
85. Zijlstra F, Fioretti P, Reiber JHC, Serruys PW. Which cineangiographically assessed anatomic variable correlates best with functional measurements of stenosis severity? A comparison of quantitative analysis of the coronary cineangiogram with measured coronary flow reserve and exercise/redistribution thallium-201 scintigraphy. J Am Coll Cardiol 1988; 12: 686-691.
86. Reiber JHC. Angiography and digital radiography. Curr Opin Cardiol 1989; 4: 853-862.
87. Berry JJ, Pieper K, Hanson MW, Burnette M, Skelton TN, Coleman RE. Cardiac wall motion analysis, vessel patency and Q-waves are unable to differentiate PET viable from PET infarcted tissue [abstract]. J Nucl Med 1990; 31: 774.
88. Picano E, di Muro C, Gigli G, Sclavo MG, Seveso G, d' Urbano M, Gandolfo N, Cabani E, Torre F, Distante A. Dipyridamole-echocardiography in coronary artery disease. Herz 1991; 16: 379-387.
89. Curtins JM. Diagnostische Sicherheit der Echokardiographie. Berlin Heidelberg New York: Springer: 1990; 1-4: 8051.
90. Braunwald E. Heart Disease. Philadelphia: W.B. Saunders. 1980.
91. Fioretti PM, Pozzoli MM, Ilmer B, Salustri A, Cornel JH, Reijs AE, Krenning EP, Reiber JH, Feyter de PJ, Roelandt JR. Exercise echocardiography versus thallium-201 SPECT for assessing patients before and after PTCA. Eur Heart J 1992; 13: 213-219.
92. Marwick T, D'Hondt AM, Baudhuin T, Willemard B, Wijns W, Detry JM, Melin J. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? Am J Cardiol 1993; 22: 159-167.
93. Verani MS. Myocardial perfusion imaging versus two-dimensional chocardiography: comparative value in the diagnosis of coronary artery disease. J Nucl Cardiol 1994; 1: 399-414.
94. Gibbons RJ. Role of nuclear cardiology for determining management of patients with stable coronary artery disease. J Nucl Cardiol 1994; 1: S118-S130.
95. Marwick TH, Go RT, MacIntyre WJ, Saha GB, Underwood DA. Myocardial perfusion imaging with positron emission tomography and single photon emission computed tomography: frequency and causes of disparate results. Eur Heart J 1991; 12: 1064-1069.
96. 201Tl single-photon emission computed tomography in evaluation of coronary artery disease: analysis of 292 patients. Circulation 1992; 85: 1026-1031.
97. Villanueva FS, Kaul S. Assessment of myocardial perfusion in coronary artery disease using myocardial contrast echocardiography. Coronary Art Dis 1995; 6: 18-28.
98. Assoc. Am. Hosp. A national PET utilization forecast. Admin Radiol 1992; Feb.
99. Pierard LA, De Landsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990; 15: 1021-1031.
100. Hanrath P, Job F, Flachskampf F. Qualitätssicherung in der Echokardiographie. Z Kardiol 1994; 836: 15-19.
101. DePuey EG. How to detect and avoid myocardial perfusion SPECT artifacts. J Nucl Med 1994; 35: 699-702.
102. Schober O. Nuklearmedizinische In-Vivo-Untersuchung (klinische Qualitätskontrolle, 2. Empfehlung). Stuttgart: F.K. Schattauer, 1994.
103. van Train KF, Maddahi J, Berman DS, Kiat H, Areeda J, Prigent F, Freidman J. Quantitative analysis of tomographic stress thallium-201 myocardial scintigrams: a multicenter trial. J Nucl Med 1990; 31: 1168-1179.
104. van Train K, Areeda J, garda EV, Cooke CD, Maddahi J, Kiat H, Germano G, Silagan G, Folks R, Berman DS. Quantitative same-day rest-stress technetium-99m-sestamibi SPECT: definition and validation of stress normal limits and criteria for abnormality. J Nucl Med 1993; 34: 1494-1502.
105. Hoffken H, Joseph K, Alexander C, Bauer R, Berberich R. Tc-99m-2- Methoxy-Isobutyl-Isonitril in der Diagnostik der koronaren Herzkrankheit: Ergebnisse einer Multizenterstudie. Nucl Med 1990; 29: 135-143.
106. Esquerre JP, Coca FJ, Martinez SJ, Guiraud RF. Prone decubitus: a solution to inferior wall attenuation in thallium-201 myocardial tomography. J Nucl Med 1989; 30: 398-401.
107. Wackers FJT. Science, art, and artifacts: how important is quantification for the practicing physician interpreting myocardial perfusion studies? J Nucl Cardiol 1994; 1: 109-117.
108. Brown KA, Benoit L, Clements JP, Wackers FJT. Fast wash out of thallium-201 from area of myocardial infarction: possible artefact of background subtraction. J Nucl Med 1987; 28: 945-949.
109. Takahashi N, Tamaki N, Tadamura E, Kawamoto M, Torizuka T, Yonekura Y, Okuda K, Nohara R, Sasayama S, Konishi J. Combined assessment of regional perfusion and wall motion in patients with coronary artery disease with technetium-99m tetrofosmin. J Nucl Cardiol 1994; 1: 29-38.
110. Smith AM, Gullberg GT, Christian PE, Datz. FL. Kinetic-modeling of teboroxime using dynamic SPECT imaging of a canine model. J Nucl Med 1994; 35: 484-495.
111. Leppo JA, DePuey EG, Johnson LL. A review of cardiac imaging with sestamibi and teboroxime. J Nucl Med 1991; 32: 2012-2022.
112. Peters AM. A unified approach to quantification by kinetic analysis in nuclear medicine. J Nucl Med 1993; 34: 706-713.
113. Alaamer AS, Fleming JS, Perring S. Evaluation of a technique for the quantification of radioactivity and volume of an object using SPECT. Nucl Med Commun 1993; 14: 1061-1070.
114. Niemeyer MG, Laarman GL, Lelbach S, Cramer MJ. Quantitative thallium-201 myocardial exercise scintigraphy in normal subjects and patients with normal coronary arteries. Eur J Radiol 1990; 10: 19-27.
115. Grambow DW, Schwaiger M. Update in nuclear cardiology. Curr Opin Cardiol 1993; 8: 1014-20.
116. Garcia EV. Quantitative myocardial perfusion single-photon emission computed tomographic imaging: quo vadis? (Where do we go from here?) J Nucl Cardiol 1994; 1: 83-93.
117. Standke R, Hör G. Sektoranalyse der myokardialen 201 Thallium-Redistributionskinetik. Nue Comp 1980; 11: 249.
118. Eisner RL, Martin SE, Leon AR, Schmarkey LS, Worthy MA, Chu TH, Patterson RE. Inhomogeneity of gated and ungated SPECT technetium-99m sestamibi bull's-eyes in normal dogs: comparison with thallium-201. J Nucl Med 1993; 34: 281-287.
119. Faber TL, Ackers MS, Peshock RM, Corbett JR. Three dimensional motion and perfusion quantification in gated single-photon emission computed tomograms. J Nucl Med 1991; 32: 2311-2317.
120. Corbett JR. Tomographic radionuclide ventriculography: opportunity ignored? J Nucl Cardiol 1994; 1: 567-570.
121. Eilles C, Gerhards W, Strauss P, Reiners C, Börner W. EKG-getriggerte Emissions-Computertomographie der Herzbinnenräume - Methoden und klinische Ergebnisse. Der Nuklearmediziner 1982; 4/5: 275-283.
122. Garcia EV, Cullom SJ, Galt JR. Symbiotic developments in PET and SPECT to quantify and display myocardial tomography. J Nucl Med 1991; 32: 166-168.
123. Clausen M, Weismüller P, Weller R, et al. Doppleangulierte. integrale Emissionscomputeromographie (DA-ISPECT) bei der Radionuklidventrikulographie (RNV) mit rekonstruierten planaren Ansichten ausgerichtet zur langen Herzachse. Nuc Comp 1990; 21: 167-170.
124. Maul FD, Standke R, Hör G. Normwertkollektion bei nuklearkardiologischen Untersuchungen: Konzept der Geheilten-Norm. Der Nuklearmediziner 1989; 12: 109-120.
125. Hör G, Baum RP. In: Pabst HW, Adam WE, Ell PJ, Hör G, Kriegel H. Myocardial perfusion/Handbook of Nuclear Medicine, Stuttgart, New York: Fischen 1992: 127-250.
126. Maddahi J, van Train K, Prigent F, Garcia EV. Quantitative single photon emission computed thallium-201 tomography for detection and localization of coronary artery disease: optimization and prospective validation of a new technique. J Am Coll Cardiol 1989; 14: 1689-1699.
127. Marmor A, Jain D, Zaret B. Beyond ejection traction. J Nucl Cardiol 1994; 1: 477-486.
128. Kiukka JT, Bassingthwaighte JB, Henrich M, Feinendegen EE. Mathematical modelling in nuclear medicine. Eur J Nucl Med 1991; 18: 351-362.
129. Galen RS, Gambino SR. Beyond normality: the predictive value and efficiency of medical diagnoses. New York: John Wiley; 1975: 1-121.
130. Brambilla M, Inglese E, Cannizzaro G, Dondi M, Sara R, Arrigo F, Tarolo GL, A multicenter trial on interobserver and intraobserver reproducibility of segmental scoring of thallium-201 planar myocardial imaging before and after reinjection. J Nucl Med 1994; 35: 601-608.
131. Van Train KF, Garcia EV, Maddahi J, Areeda J, Cooke CD, Kiat H, Silagan G, Folks R, Friedman J, Matzer L, Bateman G, Germano T, Ziffer J, DePuey EG, Fink-Bennett D, Cloninger K, Berman DS. Multicenter trial validation for quantitative analysis of same-day rest-stress technetium-99m-sestamibi myocardial tomograms. J Nucl Med 1994; 35: 609-618.
132. Rozanski A, Diamond GA, Berman D, Forrester JS, Morris D, Swan SJ. The declining specificity of exercise ventriculography. N Engl J Med 1983; 518: 518-522.
133. Hör G, Schicha H, Standke R. Normwerte der Äquilibrium-Radionuklidventrikulographie (Ergebnisse einer Multizenterstudie). Nucl Med 1990; 29: 186-194.
134. Bonow RO. Prognostic assessment in coronary artery disease: role of radionuclide angiography. J Nucl Cardiol 1994; 1: 280-291.
135. Bauer R, Busch EvdFlierdt U, Stettmeier H, Raab W, Langhammer H, Pabst HW. Age dependence of cardiac function in healthy patients. In: Schmidt HAE, Emrich D, eds. Nuklearmedizin. Stuttgart: F.K. Schattauer; 1987; 15: 129-131.
136. Schicha H, Becker V, Lösse B, Vyska K, Feinendegen LE. Physiological alterations of the ejection fraction in man [abstract], Eur J Physiol 1978; 373: R 8.
137. Bull U, Schicha H. Nuclear medicine to image applied pathophysiology: evaluation of reserves by emission computerized tomography. Eur J Nucl Med 1990; 16: 129-135.
138. Garcia EV, Eisner RL, Patterson RE. What should we expect from cardiac PET? J Nucl Med 1993; 34: 978-980.
139. Goris ML, Thompson C, Malone LM, Franken PR. Modelling the integration of regional perfusion and function. Nucl Med Commun 1994; 15: 9-20.
140. Choi Y, Brunken RC, Hawkins RA, Huang S. Factors affecting myocardial 2-(F-18)fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med 1993; 20: 308-318.
141. Opie LH, Camici PG. Myocardial blood flow, deoxyglucose uptake, and myocyte viability in ischemia. J Nucl Med 1992; 33: 1353-1356.
142. Mullani NA. Is the Patlak graphical analysis method applicable to measurement of myocardial flow with nitrogen-13-ammonia? [letter to the Editor]. J Nucl Med 1993; 34: 1831-1832.
143. Herrero P, Hartmann JJ, Senneff MJ, Bergmann SR. Effects of time discrepancies between input and myocardial time-activity curves on estimates of regional myocardial perfusion with PET. J Nucl Med 1994; 35: 558-566.
144. Guzzardi R. Results of a multinational (1988-1991) European program on PET instrumentation. Eur J Nucl Med 1992; 19: 558.
145. Gambhir SS, Schwaiger M, Huang S, Krivokapich J, Schelbert HR, Nienaber CA, Phelps ME. Simple non-invasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med 1989; 30: 359-366.
146. Correia J. A bloody future for clinical PET. J Nucl Med 1992; 32: 620-622.
147. Gropler RJ, Siegel BA, Lee KJ, Moerlein SM, Perry DJ, Bergmann SR, Geltman EM. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med 1990; 31: 1749-1756.
148. Kim CK, Gupta NC, Chandramouli B, Alavi A. Standardized uptake values of FDG: body surface area correction is preferable to body weight correction. J Nucl Med 1994; 35: 164-167.
149. Hamberg LM, Hunter GJ, Alpert NM, Choi NC, Babich JW, Fischman AJ. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med 1994; 35: 1308-1312.
150. Czernin J, Müller P, Chan S, Brunken RC, Porenta G, Krivokapich J, Chen K, Chan A, Phelps ME, Schelbert HR. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 1993; 88: 62-69.
151. Laubenbacher C, Rothley J, Sitomer J, Beanlands R, Sawada S, Sutor R, Muller D, Schwaiger M. An automated analysis program for the evaluation of cardiac PET studies: initial results in the detection and localization of coronary artery disease using nitrogen-13-ammonia. J Nucl Med 1993; 34: 968-978.
152. Hör G. Positronen-Emissions-Tomographie (PET) - Von der Forschung zur Klinik. Dtsch Ärztebl 1993; 90: A1-1883-A1-1891.
153. Gould KL. PET perfusion imaging and nuclear cardiology. J Nucl Med 1991; 32: 579-606.
154. Go R, Marwick TH, McIntyre WJ, al. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med 1990; 31: 1899-1905.
155. Herrero P, Markham J, Shelton ME, Bergmann SR. Implementation and evaluation of a two-compartment model for quantification of myocardial perfusion with Rubidium-82 and positron emission tomography. Circ Res 1992; 70: 496-507.
156. vom Dahl J, Muzik O, Wolfe E, Schwaiger M. Rubidium-82 (Rb-82) kinetics assessed by positron emission tomography (PET) for characterization of myocardial viability [abstract] J Am Coll Cardiol 1992; 19: 142A.
157. Reske SN, Henrich MM, Mate E, Weller R, Glatting G, Grimmerl S, Weismüller R, Stollfuß J, Hombach V. Nichtinvasive Bestimmung der myokardialen Ruhedurchblutung mit 82 Rb PET bei Patienten im Vergleich zur Argonmethode. Nucl Med 1993; 32: 276-281.
158. Pennell DJ, Ell PJ. Whole-body imaging of thallium-201 after six different stress regimens. J Nucl Med 1994; 35: 425-428.
159. Blanksma PK, Willemsen ATM, Meeder JG, de Jong RM, Anthonio RL, Pruim J, Vaalburg W, Lie KI. Quantitative myocardial mapping of perfusion and metabolism using parametric polar map displays in cardiac PET. J Nucl Med 1995; 36: 153-158.
160. Bacharach StL, Carson RE. Whither water. J Nucl Med 1994; 35: 567-568.
161. Marinho NVS, Keogh BE, Costa DC, Ell PJ. Lammertsma AA, Camici PG. The pathophysiology of hibernating myocardium studied by PET during hyperinsulinemic-euglycemic clamp [abstract] J Nucl Cardiol 1995; 2: S3.
162. Rechavia E, Galassi AR, Araujo LI, Halson P, Lammertsma AA, Jones T, Lavender JP, Maseri A. The significance of a dipyridamole induced tc-99m-MIBI perfusion abnormality on single photon emission tomography: a quantitative validation with labelled water and positron emission tomography. Eur J Nucl Med 1992; 19: 1044-1049.
163. Bianco JA. Science behind PET. J Nucl Med 1992; 33: 1586-1587.
164. Hoffman EJ, Phelps ME, Wisenberg G, Schelbert HR, Kuhl DE. Electrocardiographic gating in positron emission computed tomography. J Comput Assist Tomogr 1979; 3: 733-739.
165. Hoffman JM, Coleman RE. Perfusion quantitation using positron emission tomography. Invest Radiol 1992; 27: S22-S26.
166. Peters AM. Graphical analysis of dynamic data: the Patlak-Rutland plot. Nucl Med Commun 1994; 15: 669-672.
167. Camici PG. Investigation of myocardial metabolism for the study of the pathophysiology of cardiac disease. J Nucl Cardiol 1994; 1: S34-39.
168. Leskinen-Kallio S, Minn H, Zasadny KR. Standardized uptake values of FDG. J Nucl Med 1994; 35: 1564.
169. Mullani NA. Is the Patlak graphical analysis method applicable to measurement of myocardial blood flow with nitrogen-13-ammonia? J Nucl Med 1993; 34: 1831-1834.
170. Eitzman DT, Schwaiger M. PET imaging for predicting revascularization outcome in ischemic heart failure. Cardio 1993; July: 38-46.
171. Hicks K, Ganti G, Mullani N, Gould KL. Automated quantitation of three-dimensional cardiac positron emission tomography for routine clinical use. J Nucl Med 1989; 30: 1787-1797.
172. Raylman RR, Caraher JM, Hutchins GD. Sampling requirements for dynamic cardiac PET studies using image-derived input functions. J Nucl Med 1993; 34: 440-447.
173. Melin JA, Vanoverschelde J-L, Bol A, Heyndrickx G, Wijns W. The use of carbon 11-labeled acetate for assessment of aerobic metabolism. J Nucl Cardiol 1994; 1: S48-S57.
174. DiChiro G, Brooks RA. PET-quantitation: blessing and curse. J Nucl Med 1988; 29: 1603-1604.
175. Burt RW, Perkins OW, Oppenheim BE, Schauwecker DS, Stein L, Wellman HN, Witt RM. Direct comparison of flourine-18-FDG SPECT, flourine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability. J Nucl Med 1995; 36: 176-179.
176. Oberhausen E, Berberich R, Ruth T, Özbeck C, Hellwig N. F-l8-FDG-Szintigraphie mit einem Ein-Kopf-SPECT-System zur Erkennung von "hibernating myocardium" und von Lungentumoren. In: Höfer R, Bergmann H, Sinzinger H, eds. Radioaktive Isotope in Klinik und Forschung. Stuttgart: Schattauer; 1993: 87-90.
177. Bax JJ, Visser FC, van Lingen A, Groeneveld ABJ, Huitink JM, Teule GJJ, Visser CA. Relation between myocardial uptake of thallium-201 chloride and flourine-18 fluorodeoxy-glucose imaged with single-photon emission tomography in normal individuals. Eur J Nucl Med 1995; 22: 56-60.
178. 99mTc-2-methoxy-isobutyl-isonitrile. A direct comparison in normal individuals and patients with coronary artery disease. Circulation 1989; 79: 1282-1293.
179. Watson DD, Smith WH, Beller GA, Vinson EL, Taillefer R. Blinded evaluation of planar technetium-99m-sestamibi myocardial perfusion studies. J Nucl Med 1992; 33: 668-675.
180. Zeiher AM, Drexler H, Wollschläger H, Just H. Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991; 84: 1984-1992.
181. MacIntyre WJ, Go R, King JL, Cook SA, Neumann DR, Saha GB, Antar MA. Clinical outcome of cardiac patients with negative thallium-201 SPECT and positive rubidium-82 PET myocardial perfusion imaging. J Nucl Med 1993; 34: 400-404.
182. Williams BR, Mullani NA, Jansen DE, Anderson BA. A retrospective study of the diagnostic accuracy of a community hospital-based PET center for the detection of coronary artery disease using Rubidium-82. J Nucl Med 1994; 35: 1586-1592.
183. Itchhaporia D. Using radionuclide techniques for evaluating patients with chest pain or unstable angina. Eur J Nucl Med 1995; 22: 185-188.
184. Bilodeau L, Theroux P, Gregoire J, Gagnon D, Arsenault A. technetium sestamibi tomography in patients with spontaneous chest pain: correlations with clinical, electrocardiographic and angiographic findings. J Am Coll Cardiol 1991; 18: 1684-1691.
185. Braat SH, De Swart H, Rigo P et al. Value of technetium Mibi to detect short lasting episodes of severe myocardial ischemia and to estimate the area at risk during coronary angioplasty. Eur Heart J 1991; 12: 30-33.
186. Taillefer R, Boucher L, Lambert R, Grégoire J, Phaneuf DC, Sikorska H, Benjamin C, Gagnon A. Tc-99m antimyosin antibody (3-48) imaging for detection of acute myocardial infarction [abstract]. J Nucl Cardiol 1995; 2: S1.
187. Verani MS. Should all patients undergo cardiac catheterization after a myocardial infarction? J Nucl Cardiol 1994; 1: S134-S146.
188. Vogel RA. Assessing stenosis significance by coronary arteriography: are the best variables good enough? J Am Coll Cardiol 1988; 12: 692-693.
189. Huber KC, Bresnahan JF, Bresnahan DR, Pellikka PA, Behrenbeck T, Gibbons RJ. Measurement of myocardium at risk by technetium-99m sestamibi: correlation with coronary angiography. J Am Coll Cardiol 1992; 19: 67-73.
190. Schelbert HR, Czernin J. Editorial: noninvasive quantification of regional myocardial blood flow: assessment of myocardial perfusion reserve and collateral circulation. J Nucl Med 1990; 31: 271-273.
191. Gregg DE. The natural history of coronary collateral development. Circ Res 1974; 35: 335-344.
192. Newman PHE. The coronary collateral circulation. Determinants and functional significance in ischemic heart disease. Am Heart J 1981; 102: 431-445.
193. Berger BC, Watson DD, Taylor GJ, Burwell LR, Martin RP, Beller GA. Effect of coronary collateral circulation on regional myocardial perfusion assessed with quantitative thallium-201 scintigraphy. Am J Cardiol 1980; 46: 365-370.
194. Gould KL. Coronary artery stenosis. New York: Elsevier, 1991.
195. Bartenstein P, Schober O, Hasfeld M, Schäfers M, Matheja P, Breithardt G. Thallium-201 single photon emission tomography of myocardium: additional information in reinjection studies is dependent on collateral circulation. Eur J Nucl Med 1992; 19: 790-795.
196. Cuoculo A, Maurea S, Pace L, Nicolai E, Nappi A, Imbriaco M, Trimarco B, Salvatore M. Resting technetium-99m methoxyisobutylisonitrile cardiac imaging in chronic coronary artery disease: comparison with rest redistribution thallium-201 scintigraphy. Eur J Nucl Med 1993; 20: 1186-1192.
197. Tubau JF, Chaitman BR, Bourassa MG, et al. Importance of coronary collateral circulation in interpreting exercise test results. Am J Cardiol 1981; 47: 27-32.
198. Levine GN, Keaney JF, Vita JA. Cholesterol reduction in cardiovascular disease - clinical benefits and possible mechanisms. N Engl J Med 1995; 332: 512-521.
199. Pace L, Cuoculo A, Maurea S, Nicolai E, Imbriaco M, Nappi A, Morisco C, Ciariello M, Trimarco B, Salvatore M. Reverse redistribution in resting thallium-201 myocardial scintigraphy in patients with coronary artery disease: relation to coronary anatomy and ventricular function. J Nucl Med 1993; 34: 1688-1692.
200. Liu P, Burns RJ. Easy come, easy go: time to pause and put thallium reserve redistribution in perspective [editorial]. J Nucl Med 1993; 34: 1692-1694.
201. Soufer R, Dey HM, Lawson AJ, Wackers FJT, Zaret BL. Relationship between reverse redistribution on planar thallium scintigraphy and regional myocardial viability: a correlative PET study. J Nucl Med 1995; 36: 180-187.
202. Thomas AC, Davies MJ, Dilly S, Duly N, Franc F. Potential errors in the estimation of coronary arterial stenosis from clinical arteriography with reference to the shape of the coronary arterial lumen. Br Heart J 1986; 55: 129-139.
203. Little WC, Constantinescu M, Applegate RJ. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild to moderate coronary artery disease? Circulation 1988; 78: 1157-1166.
204. 99mTc-sestamibi SPECT with coronary angiography in general hospital practice. Nucl Med Commun 1993; 14: 23-29.
205. Maisey MN, Lowry A, Bischof-Delaloye A, Fridrich R, Inglese E, Khalil MN, Schoot van der. JB. European multicentre comparison of thallium 201 and technetium 99m methoxyisobutylisonitrile in ischaemic heart disease. Eur J Nucl Med 1990; 16: 869-872.
206. Christian TF, O'Connor MK, Hopfenspirger MR, Gibbons RJ. Comparison of reinjection thallium-201 and resting technetium-99m-sestamibi tomographic images for the quantification of infarct size after acute myocardial infarction. J Nucl Cardiol 1994; 1: 17-28.
207. 99mTc-sestamibi. London: Martin Dunitz, 1993.
208. 201Tl? (Erste Frankfurter Erfahrungen mit Literaturresumee.) Der Nuklearmediziner 1989; 12: 133-146.
209. Buell U, Dupont F, Uebis R, Kaiser HJ, Kleinhans E, Reske SN, Hanrath P. Tc-99m-methoxy-isobutyl-isonitrile SPECT to evaluate a perfusion index from regional myocardial uptake after exercise and at rest. Results of a four hour protocol in patients with coronary heart disease and in controls. Nucl Med Commun 1990; 11: 77-94.
210. 201Tl myocardial SPECT and betaendorphin levels in patients with suspected silent ischemia. Nucl Med 1990; 29: 153-157.
211. de Kock M, Melin JA, Pouleur H, Rousseau MF. Alterations in myocardial metabolism and function at rest in stable angina pectoris: relations with the amount of exercise-induced thallium-201 perfusion defect. Cath Cardiovasc Diagn 1986; 12: 391-398.
212. Germano G, Chua T, Kavanagh PB, Kiat H, Berman DS. Detection and correction of patient motion in dynamic and static myocardial SPECT using a multi-detector camera. J Nucl Med 1993; 34: 1349-1355.
213. Croll MN. Historic perspective. Semin Nucl Med 1994; 24: 3-10.
214. Tsui BMW, Zhao X, Frey EC, McCartney WH. Quantitative single-photon emission computed tomography: basics and clinical considerations. Semin Nucl Med 1994; 24: 38-65.
215. Borges-Neto S, Coleman E, Potts JM, Jones RH. Combined exercise radionuclide angiography and single photon emission computed tomography perfusion studies for assessment of coronary artery disease. Semin Nucl Med 1991; 21: 223-229.
216. Mannting F, Morgan-Mannting MG. Gated SPECT with technetium-99m-sestamibi for assessment of myocardial perfusion abnormalities. J Nucl Med 1993; 34: 601-608.
217. Bourguignon MH, Buseman-Sokole E, Jones BE, Hör G. Protocols for selection of cardiac radionuclide studies for use as data base of normal studies and typical patterns of diseases. In: COST PROJECT B 2, Eur. Ass. Nucl. Med., Comm. of Europ. Commun., 1991.
218. Kugi A, Bergmann H. Erste Erfahrungen mit der Inbetriebnahme von SPECT-Kameras mit mehreren Detektorköpfen. Acta Med Austriaca (Vienna) 1993; 20: 27-31.
219. Upton MT, Rerych SK, Newman GE, Port S. Detecting abnormalities in left ventricular function during exercise before angina and ST segment depression. Circulation 1980; 62: 341-349.
220. Günalp B, Uyan C, Dokumaci B, Özgüven M, Vardareli E, Öztürk E, Özkan M, Isik E, Bayhan H. Dobutamine stress radionuclide ventriculography for the detection of coronary artery disease. Nucl Med Commun 1993; 14: 471-478.
221. Steingart RM, Wassertheil-Smoller S, Tobin JN, Wexler J, Budner N. Nuclear exercise testing and the management of coronary artery disease. J Nucl Med 1991; 32: 753-758.
222. Gibbons RJ, Fyke RE, Clements IP, Lapeyre AC, Zinsmeister AR, Brown ML. Noninvasive identification of severe coronary artery disease using exercise radionuclide angiography. J Am Coll Cardiol 1988; 11: 28-34.
223. Beller GA. New directions in myocardial perfusion. Clin Cardiol 1993; 16: 86-94.
224. Berman DS, ed. A Symposium: technetium-99m myocardial perfusion imaging agents and their relation to thallium-201. Am J Cardiol 1990; 66: 1E-96E.
225. Taillefer R, Gagnon A, Laflamme L, Grégoire J, Leveille J, Phaneuf DC. Same day injection of Tc-99m methoxy isobutyl isonitrile (hexamibi) for myocardial tomographic imaging: comparison between rest-stress and stress-rest injection sequences. Eur J Nucl Med 1989; 15: 113-117.
226. Salustri A, Pozzoli MA, Hermans W, Ilmer B, Cornel JH, Reijs AEM, Roelandt JRTC, Fioretti PM. Relationship between exercise echocardiography and perfusion single-photon emission computed tomography in patients with single vessel coronary artery disease. Am Heart J 1992; 124: 75-83.
227. Patterson RE, Horowitz STF, Eng C, Meller J. Goldsmith ST. Can noninvasive exercise test criteria identify patients with left main or 3-vessel coronary disease after a first myocardial inafarction? Am J Cardiol 1983; 51: 361-372.
228. Nicod P, Corbett JR, Firth BG, Lewis SE, Rude RE, Wilierson R, Huxley JT. Prognostic value of resting and submaximal exercise radionuclide ventriculography after acute myocardial infarction in high risk patients with single and multi-vessel disease. Am J Cardiol 1983; 52: 30-36.
229. Gewirtz H, Fischman AJ, Abraham S, Gilson M, Strauss HW, Alpert NM. Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction. J Am Coll Cardiol 1994; 23: 851-859.
230. Klepzig H Jr, Standke R, Baum RP, Tezak S, Mildenberger D, Maul FD, Hör G, Kaltenbach M. Vergleich von Belastungs-EKG und Radionuklid-Ventrikulographie bezüglich des Nachweises einer Myokardischämie bei isolierten Stenosen des Ramus interventricularis anterior. Nucl Med 1988; 27: 57-62.
231. Leppo J. Thallium washout analysis: fact or fiction? J Nucl Med 1987; 28: 1058-1060.
232. Bateman TM, Maddahi J, Gray RR. Diffuse slow wash out of myocardial thallium-201: a new scintigraphic indicator of extensive coronary artery disease. J Am Coll Cardiol 1984; 4: 55-64.
233. Maddahi J, Abdulla A, Garcia EV, Swan HJC, Berman DS. Noninvasive identification of left main and triple vessel coronary artery disease: improved accuracy using quantitative analysis of regional myocardial stress distribution and wash-out of thallium-201. J Am Coll Cardiol 1986; 7: 53-60.
234. Valette H, Bourguignon MH, Le Guludec D, Merlet P. ECG gated thallium-201 myocardial images: value in detecting multivessel disease in patients on antianginal therapy 1-3 months after myocardial infarction. Eur J Nucl Med 1988; 13: 551-556.
235. Ilmer B, Riejs AEM, Fioretti P, Reiber JHC. Comparative study of three different approaches on the estimation of the lung-heart ratio in thallium 201 scintigrams in relation to the extent of coronary artery disease and left ventricular function. Eur J Nucl Med 1991; 18: 252-258.
236. Kurata C, Tawarahara K, Taguchi T, Sakata K, Yamazaki N, Naitoh Y. Lung thallium-201 uptake during exercise emission computed tomography. J Nucl Med 1991; 32: 417-423.
237. Roesler H, Hess T, Weiss M, Noelpp U, Mueller G, Hoeflin F, Kinser J. Tomoscintigraphic assessment of myocardial metabolic heterogeneity. J Nucl Med 1983; 24: 285-296.
238. Caldwell JH, Williams DL, Harp GD. Quantitation of size of relative myocardial perfusion defect by SPECT. Circulation 1984; 70: 1048-1056.
239. Gibson WS, Christian TF, Pellikka PA, Behrenbeck T, Gibbons RJ. Serial tomographic imaging with technetium-99m sestamibi for the assessment of infarcl-related arterial patency following reperfusion therapy. J Nucl Med 1992; 33: 2080-2085.
240. Kloner RA, Pryzklenk K, Shook T. The role of preconditioning ischemia in the reduction of myocardial infarct size. Edit Cardiol 1995; 1: 67-71.
241. Taillefer R, Laflamme L. Myocardial perfusion imaging with Tc-99m-methoxy-isobutyl-isonitrile (MIBl): comparison of short and long time intervals between rest and stress injections. J Nucl Med 1987; 28: 662.
242. Taillefer R, Dupras G, Sporn V, Rigo P, Leveille J, Boucher P, Perez-Balino N, Camin LL, McKusick KA. Myocardial perfusion imaging with a new radiotracer - technetium-99m-Hexamibi (methoxy isobutyl isonitrile): comparison with thallium-201 imaging. Clin Nucl Med 1989; 14: 89-95.
243. Taillefer R, Lambert R, Essiambre R, Phaneuf DC, Leveille J. Comparison between thallium-201, technetium-99m-sestamibi and technetium-99m-teboroxime planar myocardial perfusion imaging in detection of coronary artery disease. J Nucl Med 1992; 33: 1091.
244. Maurea S, Cuocolo A, Pace L, Nicolai E, Nappi A, Imbriaco M, Trimarco B, Salvatore M. Left ventricular dysfunction in coronary artery disease: comparison between rest-redistribution thallium-201 and resting technetium-99m methoxyisobutyl isonitrile cardiac imaging. J Nucl Cardiol 1994; 1: 65-71.
245. Nienaber CA, Salge D, Spielmann RP, Todd C, Bleifeld W. Dipyridamol-Thallium-201 Tomographie nach akutem Myokardinfarkt: Bedeutung für die kardiale Risikostratifizierung. Z Kardiol 1990; 79: 633-640.
246. Jones RH. Use of radionuclide measurements of left ventricular function for prognosis in patients with coronary artery disease. Semin Nucl Med 1987; 17: 95-103.
247. Iskandrian AS, Heo J, Decoskey D, Askenase A, Segal BL. Use of exercise thallium-201 imaging for risk stratification of elderly patients with coronary artery disease. Am J Cardiol 1988; 61: 269-272.
248. Mazzotta G, Pace L, Bonow RO. Risk stratification of patients with coronary artery disease and left ventricular dysfunction by exercise radionuclide angiography and exercise electrocardiography. J Nucl Cardiol 1994; 1: 529-536.
249. Nemeroski M, Shah PK, Pichler M, Berman DS, Shellock F, Swan HJC. Radionuclide assessment of sequential changes in left and right ventricular function following first acute transmural myocardial infarction. Am Heart J 1982; 104: 709-717.
250. Iskandrian AS, Hakki AH. Left ventricular function in patients with coronary heart disease in the presence or absence of angina pectoris during exercise radionuclide ventriculography. J Cardiol 1984; 53: 1239-1243.
251. Port St, Cobb FR, Coleman E, Jones RH. Effect of age on the response of the left ventricular ejection fraction to exercise. N Engl J Med 1980; 303: 1134-1137.
252. Sechtem U, Schicha H, Kardiale Diagnostik mit konventioneller Szintigraphie, Positronenemissionstomographie und Kernspintomographie. Med Klin 1993; 88: 540-542.
253. Pfeffer MA, Braunwald E, Members Multicenter. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction (results of the survival and ventricular enlargement trial). N Engl J Med 1992; 327: 669-667.
254. Konstant MA, Kronenherg MW, Udelson JE, Kinan D, Metherall J, Dolan N. Effectiveness of preload reserve as a determinant of clinical status in patients with left ventricular dysfunction. Am J Cardiol 1992; 69: 1591-1595.
255. Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction (Potential mechanisms and early predictors). Circulation 1993; 87: 755-763.
256. Camici P, Kaski JC, Shea MJ, Selwyn AP, Jones T, Maseri A. Increased myocardial glucose utilization in exertional angina. Circulation 1983; 68: 324.
257. Camici P, Araujo L, Spinks T, Jones T, Maseri A. Myocardial blood How and glucose metabolism in exercise induced and spontaneous ischemia. Eur J Nucl Med 1986; 12: S49-S50.
258. Patterson RE, Shonkoff D, Churchwell AL, Gober A, Neckman C, Dunn D, Cloninger KG, Battey LL, Liberman HA, Morris DC, Reisner RL. How frequent is "silent ischemia" during exercise SPECT-Tl-201? [abstract]. J Nucl Med 1987; 28: 587.
259. Weidinger F, Sochor H, Czernin J, Pospischil E, Glogar D. Characteristics of transient ischaemic episodes in patients with silent and symptomatic exercise-induced myocardial ischaemia. Eur-Heart J 1988; 9: 1081-1087.
260. Hartmann A, Maul FD, Zimny M, Klepzig H Jr. Vallbracht C, Kneissl HG, Schräder R, Hör G, Kaltenbach M. Impairment of left ventricular function during coronary angioplastic occlusion evaluated with a nonimaging scintillation probe. Am J Cardiol 1991; 68: 598-602.
261. Breisblatt WM. Continuous radionuclide monitoring of left ventricular function: has the time come? J Nucl Med 1991; 32: 44-47.
262. Kayden DS, Remetz MS, Cabin HS, Deckelbaum LI, Cleman MW, Wackers FJT, Zaret BL. Validation of continuous radionuclide left ventricular functioning monitoring in detecting silent myocardial ischemia during balloon coronary angioplasty of the left anterior defending coronary artery. Am J Cardiol 1991; 67: 1339-1343.
263. Adams ME, Antczak-Bouckoms A, Frazier HS, Lau J, Chalmers TC, Mosteller F. Assessing the effectiveness of ambulatory cardiac monitoring for specific clinical indications. Int J Technol Assess Health Care 1993; 9: 97-101.
264. Wilson RA, Sullivan PJ, Mooere RH et al. An ambulatory ventricular function monitor: validation and preliminary results. Am J Cardiol 1983; 52: 601-606.
265. Pancholy SB, Schalet B, Kuhlmeier V, Cave V, Heo J, Iskandrian AS. Prognostic significance of silent ischemia. J Nucl Cardiol 1994; 1: 434-440.
266. Deedwania PC. Increased demand versus supply and the circadian variations in ambulatory myocardial ischemia (therapeutic implications). Circulation 1993; 88: 328-331.
267. Cohn PF, Brown EJ Jr. Wynne J. Global and regional left ventricular ejection fraction abnormalities during exercise in patients with silent myocardial ischemia. J Am Coll Cardiol 1983; 3: 931-933.
268. Maes A, Flameng W, Nuyts J, Borgers M, Shivalkar B, Ausma J, Bormans G, Sehiepers C, De Roo M, Mortelmans L. Histological alteration in chronically hypofused myocardium - correlations with PET findings. Circulation 1994; 90: 735-745.
269. Lucignani G, Paolini G, Landoni C, Zuccari M, Paganelli G, Galli L, Di Credico G, Vanoli G, Rossetti C, Mariani MA, Gilardi MC, Colombo F, Grossi A, Fazio F. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease. Eur J Nucl Med 1992; 19: 874-881.
270. Deanfield JE, Maseri A, Selwyn AP, et al. Myocardial ischemia during daily life in patients with stable angina: its relation to symptoms and heart rate. Lancet 1983; II: 753-758.
271. Tamaki N, Yonekura Y, Yamashita K. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989; 64: 860-865.
272. Deussen A, Henrich M, Hamacher K, Borst MM, Herzog H, Coenen HH, Stöcklin G, Feinendegen LE, Schrader J. Noninvasive assessment of regional cardiac adenosine using positron emission tomography. J Nucl Med 1992; 33: 2138-2144.
273. Maddahi J, Schelbert H, Brunken R, Di Carli M. Role of thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular dysfunction. J Nucl Med 1994; 35: 707-715.
274. Camici PG, Marinho NVS. Assessment of myocardial viability and the role of surgery. Curr Opin Cardiol 1993; 8: 927-931.
275. Brunken R, Schwaiger M, Grover-McKay M, Phelps ME, Tillish J, Schelbert HR. Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. J Am Coll Cardiol 1987; 10: 557-567.
276. Nunn AD. Is nuclear medicine viable and can it measure viability? J Nucl Med 1993; 34: 924-926.
277. Warwick TH, Nemec JJ, Lafont A, Salcedo EE, Maclntyre WJ. Prediction of post exercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization. Am J Cardiol 1992; 69: 854-859.
278. Maddahi J, DiCarli M, Davidson M, Khanna S, Rokhsar S, Tillisch J, Laks H, Schelbert H, Philips M. Prognostic significance of PET assessment of myocardial viability in patients with left ventricular dysfunction [abstract]. J Am Coll Cardiol 1992; 19: 142A.
279. Schwaiger M, Muzik O. Assessment of myocardial perfusion by positron emission tomography. Am J Cardiol 1991; 67: 35D-43D.
280. Miron SD, Finkelhor R, Bahler R, Sodee B, Bellon EM. Use of Tc-99m sestamibi infusion for detection of hibernating myocardium - a preliminary report. Clin Nucl Med 1995; 20: 440-445.
281. Eitzman D, Al-Aouar Z, Kanter HL, vom Dahl J, Kirsh M, Deeb GM, Schwaiger M. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992; 20: 559-565.
282. 18F]fluorodeoxyglucose kinetic model in calculations of myocardial glucose metabolism during ischemia. J Nucl Med 1983; 1060-1064.
283. Dreyfuss GD, Duboc D, Blasco A, Vigoni F, Dubois C, Brodaty D, de Lentdecker P, Bachet J, Goudot B, Guilmet D. Myocardial viability assessment in ischemie cardiomyopathy: benefits of coronary revascularization. Ann Thorac Sura 1994; 57: 1402-1408.
284. Reifart N, Maul FD, Mützel E, Sarai K, Hör G, Kaltenbach M, Satter P. Aortokoronare Bypassoperation bei erheblich reduzierter linksventrikulärer Funktion infolge chronischer Ischämie. Dtsch Med Wochenschr 1984: 109: 1671-1677.
285. Reifart N, Kneissl D, Klepzig H Jr, Hör G, Farbdopplerechokardiographie und Radionuklid-Ventrikulographie bei Aorten- und Mitralinsuffizienz. Zschr Kardiol 1988; 77: 222-226.
286. Coleman RE. Will clinical PET become a reality? Nucl Med Commun 1993; 14: 407-408.
287. Weinberg H, Huang SC, Hofman EJ, Araujo L. Nienaber C, Grover-McKay M, Schelbert HR. Validation of PET-acquired input functions for cardiac studies. J Nuel Med 1988; 29: 241-247.
288. Burns RJ. Rubidium-82 PET - Essential or not? J Nucl Med 1993; 34: 1834.
289. Di Carli M, Schelbert H, Asgarzadie F, et al. Is there a relationship between myocardial viability and change in heart failure post revascularisation in patients with poor LV function? J Nucl Med 1994; 35: 49P.
290. Hartmann A, Baum RP, Klepzig H Jr, Huth A, Mondorf U, Herrmann G, Cielinski G, Olbrich HG, Hör G, Krause E, Kaltenbach M, Kober G. Erfahrungen mit dem Einsatz der monoklonalen Indium-111-Antimyosin-Szintigraphie in der Diagnostik von Abstoßungsepisoden nach orthotoper Herz-transplantation. Zschr Kardiol 1991; 80: 454-458.
291. Hartmann A, Klepzig H Jr, Standke R, Olbrich HG, Cieslinski G, Kober G, Baew-Christow T, Maul FD, Hör G, Satter P, Kaltenbach M, Multiparameteranalyse mittels Radionuklidventrikulographie in der Beurteilung der linksventrikulären Funktion nach Herztransplantation. Nucl Med 1991; 30: 1-6.
292. Happ J, Gerspach A, Olbrich HG, Klepzig H Jr. Standke R, Nitz C, Baum RP, Maul FD, Dannert U, Krause E, Satter P, Hör G. Radionuclide ventriculography in patients with cardiac allograft. In: Schmidt HAE, Czernay L. eds. Nuclear medicine-new trends and possibilities. Stuttgart: Schattauer; 1988: 247-249.
293. Hall TS, Baumgartner WA, Borkon AM, LaFrance ND, Traill TA, Norris S, Hutchins GM, Brawn J, Reitz BA. Diagnosis of acute cardiac rejection with antimyosin monoclonal antibody, phosphorus nuclear magnetic resonance imaging, two-dimensional echocardiography, and endocardial biopsy. J Heart Transplant 1986; 5: 419-424.
294. Jayaweera AR, Kaul S. Quantifying myocardial blood flow with contrast echocardiography. Am J Cardiac Imag 1993; 7: 317-335.
295. 201Tl. Nucl Med 1994; 33: 106-112.
296. Mondorf UF, Baum RP, Herrmann G, Hertel A, Krause E, Kober G, Hör G. Noninvasive diagnosis of rejection episodes following heart transplantation. In: Klapdor R, ed. Recent results in tumor diagnosis and therapy. Munich: Zuckschwerdt; 1990: 396-401.
297. Ballester-Rhodes M, Carrio I, Abadal-Berini L, Obrador-Mayol D, Berna-Roqueta L, Caralps-Riera JP. Patterns of evolution of myocyte damage after human heart transplantation detected by indium-111-monoclonal antimyosin. Am J Cardiol 1988; 62: 623-627.
298. Morguet AJ, Munz DL, Kreuzer H, Enirich D. Scintigraphic detection of inflammatory heart disease. Eur J Nucl Med 1994; 21: 666-674.
299. Hertel A, Maul FD, Baum RP, Niesen A, Hartmann A, Zöller A, Klepig H, Hör G. Radionuclide ventriculography compared with antimyosin imaging in long term follow-up of heart transplantation [abstract]. Eur J Nucl Med 1994; 21: 797.
300. Jonas M, Weyand M, Höcker H, Puskas C, Sciuk J, Rahmel A, Breithard G, Scheld HH, Schober O. In-111-Antimyosin-Antikörper-Szintigraphie: Klinische Relevanz in der Nachsorge herztransplantierter Patienten. Nucl Med 1995; 34: A128.
301. Carrio I, Estorch M, Berna L, Ballester M, Obrador D, Schmidt HAE, Martinez-Dunker C. Chambron J. Noninvasive follow-up of heart transplant patients with quantitative antimyosin scintigraphy/nuclear medicine (quantitative analysis in imaging and function). Stuttgart New York: Schattauer; 1990: 182-183.
302. Carrio I, Berna L, Ballester M, Estorch M, Obrador D, Cladellas M, Abdadal L, Ginjauma M. Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection. J Nucl Med 1988; 29: 1893-1900.
303. Ballester M, Obrador D, Carrio I, Auge JM, et al. Indium-111 monoclonal antimyosin antibody studies after the first year of heart transplantation (identification of risk groups for developing rejection during long-term follow-up and clinical implications). Circulation 1990; 82: 2100-2108.
304. Ballester M, Obrador D, Carrio I, Moya C, Auge JM, Bordes R, Marti V, et al. Early postoperative reduction of monoclonal antimyosin antibody uptake is associated with absent rejection-related complications after heart transplantation. Circulation 1992; 85: 61-68.
305. Krause BJ, Gunner C, Maul FD, Kranert TW, Baum RP, Hör G. Double isotope technique validation in the assessment of sympathetic reinnervation after heart transplantation using I-123-MIBG and Tl-201: patient and phantom studies [abstract]. Eur J Nucl Med 1994; 21: 788.
306. Gürtner C, Krause BJ, Klepzig H Jr, Herrmann G, Lelbach S, Vockert L, Hartmann A, Maul FD, Kranert WT, Mutschler E, Hübner K, Hör G. Sympathetic reinnervation after heart transplantation: dual isotope neurotransmitter-scintigraphy, norepinephrine content and immunohistochemistry [abstract]. J Nucl Cardiol 1995; 2: S113.
307. Schwaiger M, Kalff V, Rosenspire K, Haka MS. Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation 1990; 82: 457-464.
308. Merlet P, Agostini D, Bourguignon MH, Richalet JP, Jouve B, Lellouche D, Castaigne A, Vernant P, Valette H, LeGuludec D, Raynaud C, Syrota A. Assessment of myocardial sympathetic stores with I-123 metaiodobenzylguanidine (MlBG) in congestive heart failure and normal volunteers. In: Schmidt HAE. Buraggi GL, eds. Nuklearmedizin. Stuttgart: Schattauer; 1989: 275-278.
309. Merlet P, Valette H, Dubois-Rande JL, Moyse D, Duboc D, Dove P, Bourguignon MH, Benvenuti C, Duval AM, Agostini D, Loisance D, Castaigne A, Syrota A. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992; 33: 471-477.
310. Schwaiger M, Hutchins G, Rosenspire K, Haka M, Wieland DM. Quantitative evaluation of the sympathetic nervous system by PET in patients with cardiomyopathy [abstract]. J Nucl Med 1990; 31: 792.
311. Schwaiger M, Guibourg H, Rosenspire K, McClumihan T. Effect of regional myocardial ischemia on sympathetic nervous system as assessed by fluorine-18-Metaraminol. J Nucl Med 1990; 31: 1352-1357.
312. Schwaiger M, Huchins GD, Kalff V, Rosenspire K, Haka MS, Mallette S, Deeb GM, Abrams GD, Wieland D. Evidenee for regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography. J Clin Invest 1991; 87: 1681-1690.
313. Strauer B-E, Kandolf R, Mall G, Maisch B, Mertens T, Schwartzkopf B, Schultheiß H-P. Myokarditis - Kardiomyopathie. Konsensus-Bericht 100. Tagung der Deutsehen Gesellschaft für Innere Medizin, Wiesbaden, 13.4.1994. Med Klin 1994; 89: 23-38.
314. Sehoolmeester WL, Simpson AG, Sauerbrunn BJ, Fletcher RD. Radionuclide angiographic assessment of left ventricular function during exercise in patients with a severely reduced ejection fraction. Am J Cardiol 1981; 47: 804-809.
315. Huguet M, Garcia A, Francino A, Setoain FJ, Vidal S, Sola M, Herranz R. Myocardial uptake of antimyosin antibody in idiopathic dilated cardiomyopathy and its relation to functional and morphological parameters. Nucl Med Commun 1994; 15: 943-948.
316. Morguet AJ, Munz DL, Kreuzer H, Emrich D. Immunoscintigraphy with 111 In antimyosin Fab. Nucl Med Commun 1990; 11: 727-735.
317. Henderson EB, Kahn JK, Corbett JR, Jansen DE, Pippin JJ, Kulkarni P, Ugolini V. Abnormal 1-123 metaiodobenzylguanidine myocardial wash-out and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 1988; 78: 1192-1199.
318. Gürtner C, Werner RJ, Wendt T, Krause BJ, Winten G, Teupe C, Maul FD, Holzmann H, Hör G, Evaluation of cardiac sympathetic nervous system in systemic sclerosis using 123-I-metaiodobenzylguanidine (MIBG) and SPFCT [abstract]. Eur J Nucl Med 1994; 21: 787.
319. Gürtner C, Schacherer C, Zickmann J, Krause BJ, Maul FD, Klepzig jr. H, Hör G. Evaluation of the sympathetic nervous system with I-123-Metaiodobenzylguanidine in silent ischemia [abstract]. Eur J Nucl Med 1994; 21: 787.
320. Rosen SD, Camici PG. Syndrome X: radionuclide studies of myocardial perfusion in patients with chest pain and normal coronary arteriograms. Eur J Nucl Med 1992; 19: 311-314.
321. Schuler G, Opherk D, Manthey J, Schwarz F, Kühler W. A prognostic marker in patients with angina and a normal coronary arteriogram. Prim Cardiol 1991; 17: 57-66.
322. Kaski JC. Angina peetoris with normal coronary arteries: syndrome X. London: Kluwer: 1994: 304.
323. Maisch B. Zwischen Intervention, Immunologie und Molekularbiologie - Perspektiven einer Kardiologie der 90er Jahre. In: Graul EH, Püttner S, eds. Médicinale XX, Ierlohn 1991. Medizin und Grenzgebiete - Perspektiven für die '90er Jahre. Iserlohn: Medice: 1990; 1: 145-166.
324. Glacier JJ. Costanzo-Nordin MR. Specific heart muscle disease. Curr Opin Cardiol 1993; 8: 454-462.
325. Büll U, Strauer BE. Assessment of left ventricular muscle muss with 201-thallium myocardial imaging. In: Strauer BE, ed. Hypertonie. Berlin Heidelberg New York: Springer; 1981: 345-356.
326. Strauer BE. Koronare Mikrozirkulationsstörungen. Klin Wochenschr 1981; 59: 1125.
327. Nishimura T. Approaches to identity and characterize hypertrophic myocardium. J Nucl Med 1993; 34: 1013-1019.
328. Strauer BE, Das Hochdruckherz. Berlin Heidelberg New York: Springer, 1991.
329. Pringle SD, Dunn FG, Lorimer AR, McKillop JH. The role of nuclear cardiology in hypertension. Nucl Med Commun 1994; 15: 4-8.
330. Wasserman AG, Katz RJ, Varghese PJ, Lieboff RH, Bren GB, Schlesselman S, Varma VM, Reba RC, Ross AM. Exercise radionuclide ventriculographic responses in hypertensive patients with chest pain. N Engl J Med 1984; 311: 1276-1280.
331. Cecil MP, Pilcher WC, Eisner RL, Chu TH, Merlino JD, Patterson RE. Absence of defects in SPECT thallium-201 myocardial images in patients with systemic hypertension and left ventricular hypertrophy. Am J Cardiol 1994; 74: 43-46.
332. Ohtake T, Yokoyama I, Watanabe T, Momose T, Serezawa T, Nishikawa J,
333. Motz W, Vogt M, Strauer BE. Coronary microcirculation in hypertensive heart disase: functional significance and therapeutic implications. Clin Investig 1993; 71: 42-45.
334. Prisant LM, von Dohlen TW, Houghton JL, Carr AA, Frank MJ, A negative thallium (+/- dipyridamole) stress test excludes significant obstructive epicardial coronary artery disease in hypertensive patients. Am J Hypertens 1992; 5: 71-75.
335. Elliott PM, Kaski JC. Coronary blood flow in hypertension. Edit Cardiol 1995; 1: 27-31.
336. Caruana M, Al-Khawaja I, Lahiri A, Lewis J, Raftery EB. Radionuclide measurements of diastolic function for assessing early left ventricular abnormalities in the hypertensive patient. Br Heart J 1988; 59: 218-226.
337. Altehoefer C, vom Dahl J, Buell U. Septal glucose metabolism in patients with coronary artery disease and left bundle branch block. Coron Art Dis 1993; 4: 569-572.
338. Knapp WH, Bentrup A, Schmidt U, Ohlmeier H. Myocardial seintigraphy with thallium-201 and technetium-99m-hexakis-methoxyisobutylisonitrile in left bundle branch block: a study in patients with and without coronary artery disease. Eur J Nucl Med 1993; 20: 219-224.
339. Klepzig H Jr, Skupin M, Standke R, Satter P, Hör G, Kaltenbach M. Chronische Aorteninsuffizienz: Radionuklidventrikulographie erleichtert Operationsplanung und Einschätzung der postoperativen Prognose. Med Klin 1988; 83: 815-824.
340. Klepzig H Jr, Standke R, Nickelsen TH, Kunkel B, Maul FD, Hör G, Kaltenbach M. Combined first-pass and equilibrium radionuclide ventriculography and comparison with left ventricular/right ventricular stroke count ratio in mitral and aortic regurgitation. Am J Cardiol 1985; 55: 1048-1053.
341. Klepzig H Jr, Slandke R, Nickelsen T, Kunkel B, Maul FD, Hör G, Kaltenbach M, Volumetric evaluation of aortic regurgitation by combined first-pass-equilibrium radionuclide ventriculography. Eur Heart J 1984; 5: 317-325.
342. Klepzig H Jr, Skupin M, Mildenberger D, Standke R, Satter P, Hör G, Kaltenbach M. Chronische Aorteninsuffizienz: Vorhersage des postoperativen Verlaufs auf Grund der präoperativen Relation von links-ventrikulärem enddiastolischem Volumen zu regurgitiertem Blutvolumen. Zschr Kardiol 1987; 76: 688-698.
343. Hartmann A, Klepzig H Jr, Hör G. Valvular heart disease. In: Wagner HN Jr, Szabo Z, Buchanan JW, eds. Principles of nuclear medicine. Philadelphia: W.B. Saunders, 1995: 773-784.
344. Flynn B, Wernowsky G, Summerville DA, Castenada AR, Treves ST. Comparison of technetium-99m MIBI and thallium-201 chloride myocardial scintigraphy in infants. J Nucl Med 1989; 30: 1176-1181.
345. Prachar H, Muzika N, Dittel M, Kubiena K. Angina pectoris bei Koronaranomalie. Dtsch Med Wochenschr 1991; 13: 496-498.
346. Fioretti P, Reijs AEM, Neumann D, Taams M, Kooij PPM, Bos E, Reiber JHC, Improvement in transient and "persistent" perfusion detects on early and late post-exercise thallium-201 tomograms after coronary artery bypass grafting. Eur Heart J 1988; 12: 1332-1338.
347. Eichstädt H. Quantitative Myokardszintigraphie bei Koronaroperationen (Perioperative Diagnostik bei Aneurysma- und Bypasspatienten). Berlin Heidelberg New York: Springer. 1984.
348. Kent KM, Borer JS, Green MV, Bacharach SL, McIntosh CL, Conkle DM, Epstein StE. Effects of coronary artery bypass on global and regional left ventricular function during exercise. N Engl J Med 1978; 298: 1434-1439.
349. Alexander C, Knierim A, Huwer H, Hso T, Berberich R. Myocardial scintigraphy with Tc-99m-MIBI in the follow-up of coronary artery bypass grafting. In: Höfer R, Bergmann H, Sinzinger H. eds. Radioactive isotopes in clinical medicine and research. Stuttgart: Schattauer; 1993: 295-300.
350. Lawrie GM, Morris GC, Howell JF. Improved survival after 5 years in 1144 patients after coronary bypass surgery. Am J Cardiol 1978; 42: 709-715.
351. Hör G, Kober G, Maul FD, Klepzig H Jr, Standke R, Bittner G, Kanemoto N, Happ J, Baum RP. Nuclear cardiology results before and after percutaneous transluminal coronary angioplasty (PTCA): 1978-1986. Nucl Med Commun 1987; 8: 127-137.
352. Nienaber CA, Brockhoff CJ, PET in der interventionellen Kardiologie. Fortschr Med 1993; 111: 327-328.
353. Mintz LJ, Ingels NB, Daughters GT, Stinson EB, Alderman EL. Sequential studies of left ventricular function and wall motion after coronary arterial bypass surgery. Am J Cardiol 1980; 45: 210-216.
354. Marwick TH, Lafont A, Go RT, Underwood DA, Saha GB, MacIntyre WJ. Identification of recurrent ischemia after coronary artery bypass surgery: a comparison of positron emission tomography and single photon emission computed tomography. Int J Cardiol 1992; 35: 33-41.
355. Knuuti MJ, Nuutila P, Ruotsalainen U, Teräs M, Saraste M, Härkönen R, Ahonen A, Wegelius U, Haapanen A, Bergman J, Haarparanta M, Voipio Pulkki LM. The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET. J Nucl Med 1993; 34: 2068-2075.
356. Kober G, Grossmann R, Tauer HM, Scherer D, Maul FD, Hör G, Kaltenbach M. Silent myocardial ischemia deduced from improved left ventricular function after coronary angioplasty. In: Rutishauser W, Roskamm H, eds. Silent myocardial ischemia. Berlin Heidelberg New York: Springer; 1984: 58-65.
357. Klepzig H Jr, Standke R, Maul FD, Kaltenbach M, Hör G. Verbesserte linksventrikuläre Ruhefunktion und -perfusion nach transluminaler koronarer Angioplastik. Nucl Med 1991; 30: 55-60.
358. Hör G, Kanemoto N, Standke R, Maul FD, Klepzig H, Kober G, Kaltenbach M. Transluminale Angioplastik: Erfolgskontrollen durch Verfahren der Nuklearmedizin nach nicht-operativer Dilatation kritischer Koronararterienstenosen. Herz 1980; 5: 168-176.
359. Gyöngyüsi M, Klepzig H, Maul FD, Vallbracht C, Kaltenbuch M, Hör G, Myokardfunktion vor und nach Wiedereröffnung eines chronischen Koronarverschlusses. Z Kardiol 1992; 81: 591-595.
360. Schacherer C, Klepzig H, Heck C, Gyöngyösi M, Vallbracht C, Maul FD, Hör G. Verbesserung der Myokardfunktion und -perfusion nach Wiedereröffnung eines chronischen Koronararterienverschlusses. Z. Kardiol 1993; 82: 531-537.
361. Hombach V, Waltenberger J, Voisard R, Höher M. Rezidivstenose nach Koronarangioplastie - klinische, zellbiologische und molekulare Aspekte. Z Kardiol 1995; 84: 5-21.
362. Manyari DE. Knudtson M, Kloiber R, Roth D. Sequential thallium-201 myocardial perfusion studies after successful percutaneous transluminal coronary artery angioplasty: delayed resolution of exercise-induced scintigraphic abnormalities. Circulation 1988; 69: 86-95.
363. DePuey EG, Leatherman LL, Leachman RD, Dear WE, Massin EK. Restenosis after transluminal coronary angioplasty detected with exercise gated radionuclide ventriculography. J Am Coll Cardiol 1984; 4: 1103-1104.
364. Nishimura T, China H, Mitani I, Uehara T, Hayashida K. Delayed recovery of myocardial thallium perfusion in the infarcted myocardium after successful PTCA: assessment by serial stress thallium scan [abstract]. J Nucl Med 1990; 31: 763.
365. J.O'Keefe, Lapeyre AC III, Holmes DR, Gibbons RJ. Usefulness of early radionuclide angiography for identifying low risk patients for late restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1988; 61: 51-54.
366. Pfislerer M, Müller-Brand J, Spring P, Bassignana V, Kiowski W. Assessment of the extent of jeopardized myocardium during acute coronary artery occlusion followed by reperfusion in man using technetium-99m isonitrile imaging. Am Heart J 1991; 122: 7-12.
367. Braat SH, Rigo P, Koppenjau H, et al. The detection of the area at risk during coronary angioplasty with technetium R.P.30. [abstract]. J Nucl Med 1989; 30: 791.
368. Krause T, Dornacher T, Bonzel T, Wollschläger H, Schümichen C, Moser E. Aussagemöglichkeiten der frühen Belastungsmyokardszintigraphie nach PTCA. Nucl Med 1992; 31: 213-219.
369. Nienaber CA, Carnarius H, Thalliumszintigraphie zum Nachweis von vitalem Myokard (Beurteilung von "stunned and hibernating myocardium"). Herz 1994; 19: 7-18.
370. Gürtner C, Klepzig H Jr. Maul FD, Hartmann A, Lelbach S, Hellmann A, Hör G. Noradrenalin depletion in patients with coronary artery disease before and after percutaneous transluminal coronary angioplasty with iodine-123 metaiodobenzylguanidine and single photon emission tomography. Eur J Nucl Med 1993; 20: 776-782.
371. Gould KL. Why PET and PTCA? Imaging of the interventionist. J Invas Cardiol 1989; 1: 60-67.
372. Nienaber CA, Brunken RC, Sherman CT, Yeatman LA, Gamhihr SS. Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. J Am Coll Cardiol 1991; 18: 966-978.
373. Maseri A, Mancini P, Pesola A, et al. Method for the study of regional myocardial perfusion in patients with atherosclerotic coronary artery disease. Findings at rest after nitroglycerin and during angina pectoris. Nucl Med 1976; 15: 1-8.
374. Ramanathan KB, Bodenheimer MM, Banka VS, Helfant RH. Severity of contraction abnormalities after acute myocardial infarction in man: response to nitroglycerin. Circulation 1979; 60: 1230-1237.
375. Salel AE, Bernian DS, DeNardo GL, Mason DT. Radionuclide assessment of nitroglycerin influence on abnormal left ventricular segmental contraction on patients with coronary artery disease. Circulation 1976; 53: 975-982.
376. Borer JS, Bacharach SL, Green MV, Kent KM, Johnston GS, Epstein SE. Effect of nitroglycerin on exercise-induced abnormalities of left ventricular regional function and ejection fraction in coronary artery disease. Circulation 1978; 57: 314-320.
377. Mahmarian JJ, Fenimore NL, Marks GF, Francis MJ, Molares-Ballejo H, Verani MS, Pratt CM. Transdermal nitroglycerin patch therapy reduces the extent of exercise-induced myocardial ischemia: results of a double-blind, placebo-controlled trial using quantitative thallium-201 tomography. J Am Coll Cardiol 1994; 24: 25-32.
378. Braunwald E. The open-artery theory is alive and well - again. N Engl J Med 1993; 329: 1650-1652.
379. O'Keefe JH, Grines CL, Dewood MA, Bateman TM, Christian TF, Gibbons RJ. Factors influencing myocardial salvage with primary angioplasty. J Nucl Cardiol 1995; 2: 35-41.
380. Wackers FJT, Gibbons RJ, Verani MS, Kayden DS, Pellikka PA, Behrenbeck T, Mahmarian JJ, Zaret BL, Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy. J Am Coll Cardiol 1989; 14: 861-873.
381. Wackers FJT, Berger HJ, Weinberg MA, Zaret BL. Spontaneous changes in left ventricular function over the first 24 hours of acute myocardial infarction: implications for evaluating early therapeutic interventions. Circulation 1982; 66: 738-754.
382. Hör G. I. Zur Entwicklung der "Kardiovaskulären" Nuklearmedizin. II. Myokard- und Ventrikelszintigraphie (Radionuklid-Ventrikulographie) bei koronarer Herzkrankheit. Therapiewoche 1982; 32: 6251-6255.
383. Maul FD, Standke R, Hör G, Braune R, Geiß K, Bussmann WD. Verlauf des unkomplizierten akuten Myokardinfarktes in der frühen Hospitalphase. In: Hör G, Kaltenbach M, Maul FD, Pabst HW, eds. Interventionelle Nuklearkardiologie. Frankfurt am Main: Kern and Birner: 1985: 62-67.
384. Hör G, Bussmann WD. Kardiovaskuläre Nuklearmedizin. (Ambulanz und Intensivstation). Stuttgart: Gustav Fischer; 1984: 1-181.
385. Bussmann WD, Braune R, Geiß KR, Maul FD, Standke R, Hör G. Rhythmusstörungen, Hämodynamik, Enzymaktivitäten und regionale, nuklearmedizinisch ermittelte Ventrikelfunktion im Verlauf des akuten Myokardinfarktes. In: Hör G, Kaltenbach M, Maul FD, Pabst HW, eds. Interventionelle Nuklearkardiologie. Frankfurt: Kern and Birner: 1985: 44-61.
386. Hör G, Bussmann WD. Myokardszintigraphie in der Diagnostik des Myokardinfarktes. Inn Med 1985; 12: 159-165.
387. Hicks RJ, Melon P, Kalff V, Wolfe E, Dick RJ, Popma JJ, Topol E, Schwaiger M, Metabolic imaging by positron emission tomography early after myocardial infarction as a predictor of recovery of myocardial function after reperfusion. J Nucl Cardiol 1994; 1: 124-137.
388. Nair N, Nair CN, Advani SH, Nayak UN, Soni PS, Adriamycin cardiotoxicity evaluated by radionuclide estimations of LVEF. Ind J Nucl Med 1990; 5: 13-16.
389. Knesewitsch P, Göldel NN, Fritsch S, Moser E. Beurteilung der Adriamycin-Kardiotoxizität mittels der Äquilibrium-Radionuklid-Ventrikulographie. Nucl Med 1987; 26: 206-211.
390. Reiners C, Henning A, Müller S, Guth-Tougelidis B, Becher R. Radionukliventrikulographie (RNVG) bei der Steuerung der cytostatischen Therapie mit Anthrazyklinen [abstract]. Nucl Med 1988; 27: 48.
391. Morgan GW, McIIveen BM, Freedman A, Murray IPC. Radionuclide ejection fraction in doxorubicin cardiotoxicity. Cancer Treat Rep 1981; 65: 629-638.
392. Ritchie JL, Singer JW, Thorning D, Sorensen SB, Hamilton GW. Anthracycline cardiotoxicity: clinical and pathological outcomes assessed by radionuclide ejection fraction. Cancer 1980; 54: 1109-1116.
393. Carrió I, Lopez-Pousa A, Estorch M, Duncker D, Berná L, Torres G, de Andrés L. Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies. J Nucl Med 1993; 34: 1503-1507.
394. Estorch M, Carrio I, Berna L et al. Indium-111-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer. J Nucl Med 1991; 31: 1965-1969.
395. Alcan KE, Robeson W, Graham MC, Palestro C, Oliver FH, Benua RS. Early detection of anthracycline-induced cardiotoxicity by stress radionuclide cineangiography in conjunction with Fourier amplitude and phase analysis. Clin Nucl Med 1985; 10: 160-166.
396. Bonow RO, Udelson JE. Left ventricular diastolic dysfunction as a cause of congestive heart failure (Mechanisms and management). Ann Intern Med 1992; 117: 502-510.
397. Clements IP, Brown ML, Zinsmeister AR, Gibbons RJ. Influence of left ventricular diastolic filling on symptoms and survival in patients with decreased left ventricular systolicfunction. Am J Canliol 1991; 67: 1245-1250.
398. Wakasugi S, Fischman AJ, Babich JW, Aretz HT, Callahan RJ, Nakaki M, Wilkinson R, Strauss HW. Metaiodobenzylguanidine: evaluation of its potential as a tracer for monitoring doxorubicin cardiomyopathy. J Nucl Med 1993; 34: 1282-1286.
399. Delforge J, Syrota A, Lancon JP, et al. Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method. J Nucl Med 1991; 32: 739-748.
400. Fujita H, Katafuchi T, Uehara T, Nishimura T. Application of neural network to computer-aided diagnosis of coronary artery disease in myocardial SPECT bull's eye images. J Nucl Med 1992; 33: 272-276.
401. de Vries PH, de Vries Robbé PF. An overview of medical expert systems. Methods Inform Med 1985; 24: 57-64.
402. Rosenberg S, Itti R, Benjelloun L. Symbolic reasoning about myocardial scintigrains in PROLOG. Eur J Nucl Med 1986; 12: 65-68.
403. Höffken H, Fritsch HW, Joseph K. Evaluation of 201-thallium and 99m-Tc-sestamibi myocardial perfusion scintigraphy using neural network technology (preliminary results). In: Limouris GS, Shukla SK, Biersack H-J, eds. Radionuclides for cardiology. Athens: Mediterra; 1994: 97-104.
404. Porenta G, Dorffner G, Kundrat S, Petta P, Duit-Schedlmayer J, Sochor H. Automated interpretation of planar thallium201-dipyridamole stress-redistribution scintigrams using artificial neural networks. J Nucl Med 1994; 35: 2041-2047.
405. Goulden R, Lipton MJ. Magnetic resonance imaging and ultrafast computed tomography in cardiac tomography. Curr Opin Cardiol 1992; 7: 1007-1015.
406. Valkema R, van Eck-Smit BLF, van der Wall EE. Cardiac metabolism: a technical spectrum of modalities including positron emission tomography, single-photon emission computed tomography, and magnetic resonance spectroscopy. J Nucl Cardiol 1994; 1: 546-560.
407. Ge J, Erbel R, Gerber T, Gorge G, Koch L, Haude M, Meyer J. Intravascular ultrasound imaging of angiographically normal coronary arteries: a prospective study in vivo. Br Heart J 1994; 71: 572-578.
408. Smolarz K, Baer FM, Jungehülsing M, Theissen P, Sechtem U, Voth E, Hilger HH, Schicha H, Belastungsinduzierte Myokardbewegungsstörungen im Kernspintomogramm: Vergleich zu Belastungs-MIBI-SPECT. Nucl Med 1992; 31: 158-163.
409. Underwood SR, Firmin DN, Klipstein RH. Magnetic resonance velocity mapping: clinical application of a new technique. Br Heart J 1987; 57: 404-412.
410. Pennell DJ, Underwood SR, Manzara CM, Swanton H, Walker JM, Ell PJ, Longmore DB. Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol 1992; 70: 34-40.
411. Emanuel EJ, Emanuel LL. The economics of dying. N Engl J Med 1994; 330: 540-544.
412. ICP (Institute for Clinical PET). PET Projects 1993-1995. Arlington, Va.
413. Goldman L. Research in cardiac nuclear medicine: the difficult but critical next step. J Nucl Cardiol 1994; 1: 210-212.
414. Hör G, Sebening H, Sauer E, Dressler J, Wagner-Manslau C, Bofilias I, Lutilsy L, Pabst HW. Thallium-201 redistribution in coronary heart disease (CHD). Early and delayed myocardial scans. J Nucl Med 1977; 18: 599.
415. Dilsizian V, Bonow RO. Differential uptake and apparent 201-Tl washout after thallium reinjection: options regarding early redistribution imaging before reinjection or late redistribution imaging after reinjection. Circulation 1992; 85: 1032-1038.
416. Links JM, Frank TL, Becker LC. Effect of differential tracer washout during SPECT acquisition. J Nucl Med 1991; 32: 2253-2257.
417. Koskinen M, Pöyhönen L, Seppänen S. thallium-201 washout in coronary artery disease using SPECT - a comparison with coronary angiography.. Eur J Nucl Med 1987; 12: 609-612.
418. O'Connor MK, Cho DS. Rapid radiotracer washout from the heart: effect on image quality in SPECT performed with a single-headed gamma camera system. J Nucl Med 1992; 33: 1146-1151.
419. Bureau JF, Gaillard JF, Granier R. Ollivier JP. Diagnostic and prognostic criteria of chronic left failure obtained during exercise-201 Tl imaging. Eur J Nucl Med 1987; 12: 613-616.
420. Kahn JK, Carry MM, McGhie I, Pippin JJ, Akers MS, Corbett JR. Quantitation of postexercise lung thallium-201 uptake during single photon emission computed tomography. J Nucl Med 1989; 30: 288-294.
421. Boucher CA, ZIR LM, Beller GA, et al. Increased lung uptake of thallium-201 during exercise myocardial imaging: clinical, hemodynamic and angiographie implications in patients with coronary artery disease. Am J Cardiol 1980; 46: 189-196.
422. Homma S, Kaul S, Boucher CA. Correlates of lung/heart ratio of thallium-201 in coronary artery disease. J Nucl Med 1987; 28: 1531-1535.
423. 201Tl myocardial scintigraphy: a 3-dimensional model for the improved quantification of zones with decreased uptake. INSERM 1979; 88: 409-426.
424. Galt JR, Cullom SJ, Garcia EV. SPECT quantification: a simplified method of attenuation and scatter correction for cardiac imaging. J Nucl Med 1992; 333: 2232-2237.
425. Frey EC, Tsui BMW, Perry JR. Simultaneous acquisition of emission and transmission data for improved thallium-201 cardiac SPECT imaging using a technetium-99m transmission source. J Nucl Med 1992; 33: 2238-2245.
426. Parker JA. Quantitative SPECT: basic theoretical considerations. Semin Nucl Med 1989; 19: 3-12.
427. Eisner R, Churchwell A, Noever T, Nowak D, Cloninger K, Dunn D, Carlson W. Quantitative analysis of tomographic thallium-201 myocardial bullseye display: critical role of correcting for patient motion. J Nucl Med 1988; 29: 91-97.
428. Koral KF, Swailem EM, Buchbinder S, Clinthorne NH. SPECT dual-energy-window compton correction: scatter multiplier required for quantification. J Nucl Med 1990; 31: 90-98.
429. Wallis JW, Miller TR, Koppel P, Attenuation correction in cardiac SPECT without a transmission measurement. J Nucl Med 1995; 36: 506-512.
430. McCord ME, Bacharch SL, Bonow RO, Dilsizian V, Cuocolo A, Freedman N. Misalignment between PET transmission and emission scans: its effect on myocardial imaging. J Nucl Med 1992; 33: 1209-1214.
431. Gilland DR, Tsui BMW, Cartney WH, et al. Determination of the optimum filter function for SPECT imaging. J Nucl Med 1988; 29: 643-650.
432. Hutchins GD, Caraher JM, Raylman RR. A region of interest strategy for minimizing resolution distortions in quantitative myocardial PET studies. J Nucl Med 1992; 33: 1243-1250.
433. Resnick SM, Karp SJ, Turetsky B, Gur RE. Comparison of anatomically-defined versus physiologically-based regional localizaion: effects on PET-FDG quantitation. J Nucl Med 1993; 34: 2201-2207.
434. Eisner RL, Schmarkey LS, Martin SE, Carey D, Worthy MA, Chu TH, Horowitz SF, Patterson RE. Defects on SPECT "perfusion" images can occur due to abnormal segmental contraction. J Nucl Med 1994; 35: 638-643.
435. Massie BM, Wisneski JA, Inouye IK et al.. Detection and quantification of previous myocardial infarction by exercise-redistribution tomographic thallium-201 scintigraphy. Am J Cardiol 1984; 53: 1244-1249.
436. Gabor FV, Datz FL, Christian PE, Gullberg GT, Morton KA. Computer-assisted diagnosis of cardiac perfusion studies. J Nucl Med Technol 1991; 19: 238-244.
437. Sun KT, De Groof M, Yi J, Hansen HW, Chen K, Czernin J, Phelps ME, Schelbert HR. Quantification of the extent and severity of perfusion defects in cancine myocardium by PET polar mapping. J Nucl Med 1994; 35: 2031-2040.
438. Chiao PC, Ficaro EP, Dayanikli F, Rogers WL, Schwaiger M. Compartmental analysis of technetium-99m-teboroxime kinetics employing fast dynamic SPECT at rest and stress. J Nucl Med 1994; 35: 1265-1273.
439. Yang DC, Ragasa E, Gould L, Huang M, Reddy CVR, Saul B, Schifter D, Rainaldi D, Feld C, Tank RA, Lee S-Y, Giovanniello J. Radionuclide simultaneous dual-isotope stress myocardial perfusion study using the "three window technique". Clin Nucl Med 1993; 18: 852-857.
440. Bourguignon MH, Buseman Sokole E, Jones B, der Wall Evan. Protocols for selection of cardiac radionuclide studies for use of as a data base of normal studies and typical patterns of diseases (COST B2 Working Group II, in association with relevant working/task groups of the European Association of nuclear medicine and the European Society of Cardiology). Eur J Nucl Med 1993; 20: 59-65.
441. 18F) fluoro-2-deoxy-glucose studies. J Nucl Med 1991; 32: 733-738.
442. MacIntyre WJ, Saha GB, Go RT. Planar imaging with single-head large-field-of-view cameras: are they still the work-horse? Semin Nucl Med 1994; 24: 11-16.
443. Schelbert HR, Phelps ME, Hoffman EJ, Huang S, Selin CE, Kuhl DE. Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography. Am J Cardiol 1979; 43: 209-218.
444. Demer LL, Gould KL, Goldstein RA, Kirkeeide RL, Mullani NA, Smalling RW, Nishikawa A, Merhige ME. Assessment of coronary artery disease severity by positron emission tomography (Comparison with quantitative arteriography in 193 patients). Circulation 1989; 79: 825-835.
445. Stewart RE, Schwaiger M, Molina E, Popma J, Gacioch GM, Kalus M, Squicciarini S, Al-Aouar ZR, Schork A, Kuhl DE. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am J Cardiol 1991; 67: 1303-1310.
446. 13N-ammonia at rest and during exercise. Eur J Nucl Med 1985; 11: 246-251.
447. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert HR. Reversibility of cardiac-wall motion abnormalities predicted by positron tomography. N Engl J Med 1986; 314: 884-888.
448. vom Dahl J, Muzik O, Wolfe E, Schwaiger M. Rubidium-82 (Rb-82) kinetics assessed by positron emission tomography (PET) for characterization of myocardial viability [abstract]. J Am Coll 1992; 19: 142A.
449. 99mTc-MIBI single photon emission computed tomography. Circulation 1993; 87: 345-354.
450. Lloyd HGE, Schrader J. Adenosine metabolism in the guinea pig heart: the role of cytosolic S-adenosyl-L-homocysteine hydrolase, 5′-nucleotidase and adenosine kinase. Eur Heart J 1993; 14: 27-33.
451. Sasaki T, Enta A, Nozaki T, Ischii S, Senda M. Carbon-11-forskolin: a ligand for visualization of the adenylate cyclase related second messenger system. J Nucl Med 1993; 34: 1944-1948.
452. Sisson JC, Wieland DM, Koeppe RA, et al. Scintigraphic portrayal of beta receptors in the heart J Nucl Med 1991; 32: 1399-1407.
453. Syrota A, Paillotin G, Davy JM, Aumont MC. Kinetics of in vivo binding of antagonist to muscarinic cholinergic receptor in the human heart studied by positron emission tomography. Life Sci 1984; 35: 937-945.
454. Opie LH. Myocardial ischemia: metabolic pathways and implications of increased glycolysis, Cardiovasc Drug Ther 1990; 4: 777-790.
455. Miller WL, Burnett JF Jr. Circulating paracrine and autocrine mechanisms in heart failure. Curr Opin Cardiol 1993; 8: 376-382.
456. Urata H, Healy B, Stewart RW, Bumps FM, Husain A. Anginotensin II receptors in normal and failing human hearts. J Clin Endocrinol Metab 1989; 69: 54-65.
457. Cuocolo A, Volpe M, Mele AF, Celentano L, Neumann RD, Trimarco B, Salvatore M. Effects of atrial peptide on glomerular filtration rate in essential hypertension: a rudionuclide study. EurJ Nucl Med 1991; 18: 32-37.
458. Dietz R, Haas M, Kübler W. Atrial natriuretic factor - its possible role in hypertension and congestive heart failure. Am J Hypertens 1989; 2: 29S-33S.
459. Lambert R, Willenbrock R, Tremblay J, Bavaria G, Langlois Y, Hogan K, Tartaglia D, Flanagan RJ, Hamet P. Receptor imaging with atrial natriuretic peptide. Part I. High specific activity iodine-123-atrial natriuretic peptide. J Nucl Med 1994; 35: 628-637.
460. Ertl G, Gaudron P, Kochsiek K. Influence of angiotensin-converting enzyme inhibition on cardiac function in myocardial infarction. Am J Cardiol 1990; 65: 70G-73G.
461. Holtz J. The cardiac renin-angiotensin system: physiological relevance and pharmacological modulation, Clin Invest 1993; 71: 25-34.
462. 125I-endothelin-1 accumulation in experimental arterial wall injury. Eur J Nucl Med 1993; 20: 1141-1145.
463. Uren NG, Crake T, Lefroy DC, deSilva R, Davies GJ, Maseri A. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med 1994; 331: 222-227.
464. Zeiher AM, Drexler H, Wollschläger H, Just H. Modulation of coronary vasomotor tone in humans. Circulation 1991; 83: 391-401.
465. Nickles RJ, Nunn AD, Stone CK, Christian BT. Technetium94m-teboroxime: synthesis, dosimetry and initial PET imaging studies. J Nucl Med 1993; 34: 1058-1066.
466. Stone CK, Christian BT, Nickles RJ, Perlman SB. Technetium 94m-labeled methoxyisobutyl isonitrile: dosimetry and resting cardiac imaging with positron emission tomography. J Nucl Cardiol 1994; 1: 425-433.
467. Hör G, Maul FD, Kranert WT, Karimian-Tabriz A, Bauersachs N, Klepzig H, Baum RP, Hertel A, Diehl M, Scherer UW. Simultaneous determination of myocardial wall thickening and regional EF by PET-preliminary results [abstract]. J Nucl Cardiol 1995; 2: S117.
468. Hoffmeister HM, Müller-Schauenburg W, Helber U, Feine U, Seipel L. EKG-getriggerte FDG-Positron-Emissions-Computertomographie zur Identifikation von vitalem Myokard [abstract]. Zschr Kardiol 1995; 1: 3.
469. Yamashita K, Tamaki N, Yonekura Y, Ohtani H et al.. Quantitative analysis of regional wall motion by gated myocardial positron emission tomography: validation and comparison with left ventriculography. J Nucl Med 1989; 30: 1775-1786.
470. Nienaber CA, Hausdorf G, Spielmann RP. Myokardiale Perfusionsstörungen bei Kawasaki-Syndrom: nichtinvasiver Nachweis durch 201-Thalliumtomographie. Z Kardiol 1988; 77: 503-507.
471. Gould KL, Martucci JP, Goldberg DI, Hess MJ, Edens RP, Latifi R, Dudrick SJ. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. Circulation 1994; 89: 1530-1538.
472. Porenta G, Kuhle W, Sinha S, Krivokapich J, Czernin J, Gambhir SS, Phelps ME, Schelbert HR. Parameter estimation of cardiac geometry by ECG-gated PET imaging: validation using magnetic resonance imaging and echocardiography. J Nucl Med 1995; 36: 1123-1129.
473. Fiuza M, Pereirinha A, Pedro P, Dias E, Dionisio I, Carvalho M, Costa BB, de Padua F, Lopes MG. Importance of atropine adjunction to dobutamine stress echocardiography. Cor Europaeum 1995; 4: 69-75.
474. Grandin C, Wijns W, Melin JA, Bol A, Robert AR, Hendrickx GR, Michel C, Vanoverschelde JJ. Delineation of myocardial viability with PET. J Nucl Med 1995; 36: 1543-1552.
475. Schelbert HR. Merits and limitations of radionuclide approaches to viability and future developments. J Nucl Cardiol 1994; 1: S86-96.
476. Geltman EM. Metabolic imaging of patients with cardiomyopathy. Circulation 1991; 84: 1-265-1-272.
477. Patterson RE, Eisner RL, Horowitz SF. Comparison of cost-effectiveness and utility of exercise ECG. single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease. Circulation 1995; 91: 54-65.
478. Dayanikli F, Grambow D, Muzik O, Mosca L, Rubenfire M, Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation 1994; 90: 808-817.
479. Sambuceti G, Parodi O. Role of coronary microvascular abnormalities in coronary artery disease - implications for perfusion imaging. J Nucl Cardiol 1995; 2: 78-84.
480. Lindner JR, Kaul S. Insights into the assessment of myocardial perfusion offered by different cardiac imaging modalities. J Nucl Cardiol 1995; 2: 446-460.
481. Wu H-M, Hoh CK, Choi Y, Schelbert R, Hawkins RA, Phelps ME, Huang S-C. Factor analysis for extraction of blood time-activity curves in dynamic FDG-PET studies. J Nucl Med 1995; 36: 1714-1722.
482. Young LH, Seres JA, Lasala JM. Insulin stimulates heart glucose uptake in vivo by increasing the sarcolemma glucose transport vmax. J Am Coll Cardiol 1991; 17: 369A.
483. Schwaiger M, Sun D, England R, Nguyen NTB, Brosius F. Glucose transporter characterization in canine ischaemic myocardium [abstract]. Eur Heart J 1994; 15: 583.